Contact

All Stories

  1. GOULD EDU

    Article • JACC Advances, January 2026, Elsevier

    Professor Deepak L Bhatt

  2. Use of Cangrelor for Patients Undergoing Coronary Artery Bypass Grafting

    Article • JACC Advances, December 2025, Elsevier

    Professor Deepak L Bhatt

  3. Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes after Acute Coronary Syndrome

    Article • Circulation, December 2025, Wolters Kluwer Health

    Professor Deepak L Bhatt

  4. Heart Failure in Asian Populations

    Article • JACC Asia, December 2025, Elsevier

    Professor Deepak L Bhatt

  5. Percutaneous ventricular assist devices for percutaneous coronary interventions in older patients with heart failure: a target trial emulation

    Article • Heart, November 2025, BMJ

    Professor Deepak L Bhatt

  6. Preventing the first myocardial infarction: from reaction to action

    Article • European Heart Journal, November 2025, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  7. Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease?

    Article • European Heart Journal, November 2025, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  8. Cardiac Biomarkers, Intensive Lifestyle Intervention, and Heart Failure Subtypes in Diabetes

    Article • JACC Heart Failure, November 2025, Elsevier

    Professor Deepak L Bhatt

  9. Procedural Volume and Outcomes in Lower‐Extremity Peripheral Vascular Interventions: Insights From the NCDR Peripheral Vascular Intervention Registry

    Article • Journal of the American Heart Association, October 2025, Wolters Kluwer Health

    Professor Deepak L Bhatt

  10. Multi-Modal Deep-Learning Troponin Prediction from Electrocardiograms and Demographic Data

    Article • European Heart Journal - Digital Health, October 2025, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  11. Early Intervention vs Conservative Management in Severe Asymptomatic Aortic Stenosis

    Article • JACC Advances, October 2025, Elsevier

    Professor Deepak L Bhatt

  12. Effects of Eicosapentaenoic Acid vs Eicosapentaenoic/Docosahexaenoic Acids on Cardiovascular Mortality

    Article • JACC Advances, October 2025, Elsevier

    Professor Deepak L Bhatt

  13. Parsing the Adipokine Axis in HFpEF

    Article • Journal of the American College of Cardiology, October 2025, Elsevier

    Professor Deepak L Bhatt

  14. Opportunistic Screening for Subclinical CAD in Immune-Inflammatory Diseases

    Article • JACC Cardiovascular Imaging, October 2025, Elsevier

    Professor Deepak L Bhatt

  15. Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor Therapy

    Article • Arteriosclerosis Thrombosis and Vascular Biology, September 2025, Wolters Kluwer Health

    Professor Deepak L Bhatt

  16. Benefit of Icosapent Ethyl Across Types and Sizes of Myocardial Infarction in REDUCE-IT

    Article • European Journal of Preventive Cardiology, September 2025, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  17. Representation of Older Adults and Women in Randomized Trials of Noninvasive Imaging for Chest Pain

    Article • Circulation Cardiovascular Imaging, September 2025, Wolters Kluwer Health

    Professor Deepak L Bhatt

  18. A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular Risk

    Article • Journal of the American College of Cardiology, September 2025, Elsevier

    Professor Deepak L Bhatt

  19. Optimal medical therapy for initial management of stable angina: a call to action

    Article • European Heart Journal, August 2025, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  20. Eicosapentaenoic acid (EPA) limits the more rapid oxidation of lipoprotein(a) [Lp(a)] compared with other ApoB particles

    Article • Cardiovascular Research, August 2025, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  21. Fully Automated Diagnosis of Acute Myocardial Infarction Using Electrocardiograms and Multimodal Deep Learning

    Article • JACC Advances, August 2025, Elsevier

    Professor Deepak L Bhatt

  22. Impact of Sex and Age on Trends of Mortality From Infective Endocarditis in High-Income Countries

    Article • JACC Advances, August 2025, Elsevier

    Professor Deepak L Bhatt

  23. Lipoprotein(a) identifies patients with acute coronary syndromes who derive cardiovascular benefit from alirocumab, particularly for limb events

    Article • Journal of the American College of Cardiology, August 2025, Elsevier

    Professor Deepak L Bhatt

  24. Rapid Titration of Heart Failure Therapies by Etiology

    Article • JACC Heart Failure, August 2025, Elsevier

    Professor Deepak L Bhatt

  25. Relieving the Pressure

    Article • JACC Cardiovascular Interventions, August 2025, Elsevier

    Professor Deepak L Bhatt

  26. South Asian Representation in Cardiovascular Disease Randomized Controlled Trials

    Article • JACC Asia, August 2025, Elsevier

    Professor Deepak L Bhatt

  27. Cardiovascular Risk Factor and Disease Mortality Among Asian Indian, Chinese, and Filipino Adults in the United States, 2018 to 2023

    Article • Annals of Internal Medicine, July 2025, American College of Physicians

    Professor Deepak L Bhatt

  28. First myocardial infarction: risk factors, symptoms, and medical therapy

    Article • European Heart Journal, July 2025, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  29. Secondary analysis of the EMPACT-MI trial reveals cardiovascular–kidney efficacy and safety of empagliflozin after acute myocardial infarction

    Article • Nature Cardiovascular Research, June 2025, Springer Science + Business Media

    Professor Deepak L Bhatt

  30. P2Y 12 inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials

    Article • BMJ, June 2025, BMJ

    Professor Deepak L Bhatt

  31. Generalizability of VICTORION-1 PREVENT enrollment criteria to the United States population

    Article • American Journal of Preventive Cardiology, June 2025, Elsevier

    Professor Deepak L Bhatt

  32. Less Heart Failure But No Improvement in Quality of Life in FINEARTS-HF

    Article • Journal of the American College of Cardiology, June 2025, Elsevier

    Professor Deepak L Bhatt

  33. Outcomes Following Minimally Invasive Surgery for Intracerebral Hemorrhage in the AHA Get With The Guidelines-Stroke Registry

    Article • Stroke, June 2025, Wolters Kluwer Health

    Professor Deepak L Bhatt

  34. Percutaneous Coronary Intervention Outcomes by 5 Major Race and Ethnic Subgroups

    Article • JACC Advances, June 2025, Elsevier

    Professor Deepak L Bhatt

  35. Quantifying the Unknowns of Plaque Morphology: The Role of Topological Uncertainty in Coronary Artery Disease

    Article • Mayo Clinic Proceedings Digital Health, June 2025, Elsevier

    Professor Deepak L Bhatt

  36. Acute coronary syndromes: mechanisms, challenges, and new opportunities

    Article • European Heart Journal, May 2025, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  37. Effect of Uptitration of Recommended Heart Failure Medications on Restricted Mean Survival Time in STRONG-HF

    Article • JACC Heart Failure, May 2025, Elsevier

    Professor Deepak L Bhatt

  38. Calibration of ECG-Based Deep-Learning Algorithm Scores for Patients Flagged as High Risk for Hypertrophic Cardiomyopathy

    Article • NEJM AI, April 2025, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt

  39. Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of OD...

    Article • Circulation, April 2025, Wolters Kluwer Health

    Professor Deepak L Bhatt

  40. 1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCI

    Article • JACC Cardiovascular Interventions, April 2025, Elsevier

    Professor Deepak L Bhatt

  41. Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial

    Article • The Lancet Diabetes & Endocrinology, April 2025, Elsevier

    Professor Deepak L Bhatt

  42. Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low‐Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE‐IT Randomized Trial

    Article • Journal of the American Heart Association, March 2025, Wolters Kluwer Health

    Professor Deepak L Bhatt

  43. Emerging Pathways of Action of Eicosapentaenoic Acid (EPA)

    Article • JACC Basic to Translational Science, March 2025, Elsevier

    Professor Deepak L Bhatt

  44. Fasting vs No Fasting Prior to Percutaneous Cardiovascular Procedures

    Article • JACC Cardiovascular Interventions, March 2025, Elsevier

    Professor Deepak L Bhatt

  45. Long-Term, Patient-Level Analysis of Radiofrequency Renal Denervation in the SYMPLICITY Clinical Trial Program

    Article • JACC Advances, March 2025, Elsevier

    Professor Deepak L Bhatt

  46. Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis

    Article • Journal of the American College of Cardiology, March 2025, Elsevier

    Professor Deepak L Bhatt

  47. Expanding the triglyceride range in clinical trials: therapeutic opportunities

    Article • European Heart Journal, February 2025, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  48. Apolipoprotein C3 and risk of cardiovascular events and death in patients on optimized statin treatment after recent acute coronary syndrome

    Article • European Journal of Preventive Cardiology, February 2025, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  49. Inadequate Intensification of LDL-cholesterol lowering therapy after coronary revascularization: Insights from the GOULD registry

    Article • International Journal of Cardiology, February 2025, Elsevier

    Professor Deepak L Bhatt

  50. End-to-end deep-learning model for the detection of coronary artery stenosis on coronary CT images

    Article • Open Heart, January 2025, BMJ

    Professor Deepak L Bhatt

  51. Optimal Strategy for Complete Revascularization in ST-Segment Elevation Myocardial Infarction and Multivessel Disease

    Article • Journal of the American College of Cardiology, January 2025, Elsevier

    Professor Deepak L Bhatt

  52. Impact of Frailty on the Benefits of Dual Pathway Inhibition for the Secondary Prevention of Cardiovascular Events in the COMPASS Randomised Trial

    Article • Canadian Journal of Cardiology, January 2025, Elsevier

    Professor Deepak L Bhatt

  53. Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre‐specified analysis of the EMPACT‐MI trial

    Article • European Journal of Heart Failure, December 2024, Wiley

    Professor Deepak L Bhatt

  54. Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

    Article • ESC Heart Failure, December 2024, Wiley

    Professor Deepak L Bhatt

  55. REPLY

    Article • Journal of the American College of Cardiology, December 2024, Elsevier

    Professor Deepak L Bhatt

  56. Valvular Heart Disease-Related Mortality Between Middle- and High-Income Countries During 2000 to 2019

    Article • JACC Advances, December 2024, Elsevier

    Professor Deepak L Bhatt

  57. Mobile Stroke Unit Management in Patients With Acute Ischemic Stroke Eligible for Intravenous Thrombolysis

    Article • JAMA Neurology, December 2024, American Medical Association (AMA)

    Professor Deepak L Bhatt

  58. Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial

    Article • Circulation Cardiovascular Interventions, December 2024, Wolters Kluwer Health

    Professor Deepak L Bhatt

  59. Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes

    Article • JAMA Cardiology, December 2024, American Medical Association (AMA)

    Professor Deepak L Bhatt

  60. Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis

    Article • Circulation, November 2024, Wolters Kluwer Health

    Professor Deepak L Bhatt

  61. Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice Guidelines

    Article • Circulation, November 2024, Wolters Kluwer Health

    Professor Deepak L Bhatt

  62. International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention

    Article • JACC Cardiovascular Interventions, November 2024, Elsevier

    Professor Jolanta M Siller-Matula, Professor Deepak L Bhatt

  63. Prediction of Severe Baseline Asymptomatic Carotid Stenosis and Subsequent Risk of Stroke and Cardiovascular Disease

    Article • Stroke, November 2024, Wolters Kluwer Health

    Professor Deepak L Bhatt

  64. “A Time to Tear Down and a Time to Mend”: The Role of Eicosanoids in Atherosclerosis

    Article • Arteriosclerosis Thrombosis and Vascular Biology, November 2024, Wolters Kluwer Health

    Professor Deepak L Bhatt

  65. Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia

    Article • Annals of Internal Medicine, November 2024, American College of Physicians

    Professor Deepak L Bhatt

  66. GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors

    Article • JACC Heart Failure, November 2024, Elsevier

    Professor Deepak L Bhatt

  67. The PRECISE trial: How should patients with chest pain be tested?

    Article • Cleveland Clinic Journal of Medicine, November 2024, Cleveland Clinic Journal of Medicine

    Professor Deepak L Bhatt

  68. SGLT2 Inhibitor Prescribing in Cardiovascular-Kidney-Metabolic Syndrome

    Article • American Journal of Cardiovascular Drugs, October 2024, Springer Science + Business Media

    Professor Deepak L Bhatt

  69. Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational study

    Article • Frontiers in Pharmacology, October 2024, Frontiers

    Professor Deepak L Bhatt

  70. Smoking Habits Following Cancer Diagnosis and Heart Failure

    Article • JAMA Network Open, October 2024, American Medical Association (AMA)

    Professor Deepak L Bhatt

  71. Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trial

    Article • EuroIntervention, October 2024, Europa Digital & Publishing

    Professor Deepak L Bhatt

  72. DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases

    Article • Metabolism, October 2024, Elsevier

    Professor Deepak L Bhatt

  73. The Use of Cangrelor in Cardiogenic Shock: Insights from the CAMEO Registry

    Article • Journal of Cardiac Failure, October 2024, Elsevier

    Professor Deepak L Bhatt

  74. Interdisciplinary Engagement In Neurocardiology: A Key Opportunity

    Article • Journal of the American Heart Association, September 2024, Wolters Kluwer Health

    Professor Deepak L Bhatt

  75. Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial

    Article • European Heart Journal, September 2024, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  76. Bleeding and Thrombosis in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention

    Article • Journal of the American College of Cardiology, September 2024, Elsevier

    Professor Deepak L Bhatt

  77. Competing Risks in Clinical Trials

    Article • Journal of the American College of Cardiology, September 2024, Elsevier

    Professor Deepak L Bhatt

  78. Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure

    Article • Journal of the American College of Cardiology, September 2024, Elsevier

    Professor Deepak L Bhatt

  79. Origins and Previous Applications of Causal-Benefit Models

    Article • JACC Advances, September 2024, Elsevier

    Professor Deepak L Bhatt

  80. Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome

    Article • Journal of the American College of Cardiology, September 2024, Elsevier

    Professor Deepak L Bhatt

  81. Cost-Effectiveness of Sotagliflozin in SOLOIST-WHF

    Article • JACC Heart Failure, September 2024, Elsevier

    Professor Deepak L Bhatt

  82. Health-related quality of life with rivaroxaban plus aspirin vs. aspirin alone in chronic stable cardiovascular disease: Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial

    Article • European Heart Journal Open, August 2024, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  83. Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelines

    Article • European Heart Journal, August 2024, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  84. Multimodal fusion learning for long QT syndrome pathogenic genotypes in a racially diverse population

    Article • npj Digital Medicine, August 2024, Springer Science + Business Media

    Professor Deepak L Bhatt

  85. Role of anticoagulation therapy in modifying stroke risk associated with new-onset atrial fibrillation after non-cardiac surgery

    Article • Nature Reports Stem Cells, August 2024, Springer Science + Business Media

    Professor Deepak L Bhatt

  86. Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials

    Article • Nature Reports Stem Cells, August 2024, Springer Science + Business Media

    Professor Deepak L Bhatt

  87. Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials

    Article • The Lancet Diabetes & Endocrinology, August 2024, Elsevier

    Professor Deepak L Bhatt

  88. One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease

    Article • The American Journal of Cardiology, August 2024, Elsevier

    Professor Deepak L Bhatt

  89. Perioperative management and outcomes in patients receiving low-dose rivaroxaban and/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial

    Article • Journal of Thrombosis and Haemostasis, August 2024, Elsevier

    Professor Deepak L Bhatt

  90. Peripheral artery disease, chronic kidney disease, and recurrent admissions for acute decompensated heart failure: The ARIC study

    Article • Atherosclerosis, August 2024, Elsevier

    Professor Deepak L Bhatt

  91. Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome

    Article • Circulation, July 2024, Wolters Kluwer Health

    Professor Deepak L Bhatt

  92. Impact of gender in patients with device‐related thrombosis after left atrial appendage closure – A sub‐analysis from the multicenter EUROC‐DRT‐registry

    Article • Echocardiography, July 2024, Wiley

    Professor Deepak L Bhatt

  93. Lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp(a) Registry

    Article • Cardiovascular Diabetology, July 2024, Springer Science + Business Media

    Professor Deepak L Bhatt

  94. Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During Inflammation

    Article • Journal of the American Heart Association, July 2024, Wolters Kluwer Health

    Professor Deepak L Bhatt

  95. Colchicine for cardiovascular and limb risk reduction in Medicare beneficiaries with peripheral artery disease: emulation of target trials

    Article • European Heart Journal Open, July 2024, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  96. Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study

    Article • Journal of Clinical Lipidology, July 2024, Elsevier

    Professor Deepak L Bhatt

  97. Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping review

    Article • EClinicalMedicine, July 2024, Elsevier

    Professor Deepak L Bhatt

  98. Coronary Artery Bypass Graft Failure in Women

    Article • Journal of the American College of Cardiology, July 2024, Elsevier

    Professor Deepak L Bhatt

  99. Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis

    Article • The Lancet Diabetes & Endocrinology, July 2024, Elsevier

    Professor Deepak L Bhatt

  100. Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trial

    Article • Med, July 2024, Elsevier

    Professor Deepak L Bhatt

  101. Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low‐dose rivaroxaban, or the combination: Secondary analysis of the COMPASS randomised controlled trial

    Article • Alimentary Pharmacology & Therapeutics, July 2024, Wiley

    Professor Deepak L Bhatt

  102. Regression and stabilization of atherogenic plaques

    Article • Trends in Cardiovascular Medicine, July 2024, Elsevier

    Professor Deepak L Bhatt

  103. Effects of catheter-based renal denervation in hypertension: a systematic review and meta-analysis

    Article • June 2024, Cold Spring Harbor Laboratory Press

    Professor Deepak L Bhatt

  104. Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: is a routine invasive strategy needed?

    Article • European Heart Journal, June 2024, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  105. Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

    Article • Circulation, June 2024, Wolters Kluwer Health

    Professor Deepak L Bhatt

  106. Characteristics of High-Performing Hospitals in Cardiogenic Shock Following Acute Myocardial Infarction

    Article • The American Journal of Cardiology, June 2024, Elsevier

    Professor Deepak L Bhatt

  107. Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI

    Article • Journal of the American College of Cardiology, June 2024, Elsevier

    Professor Deepak L Bhatt

  108. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

    Article • Circulation Cardiovascular Interventions, June 2024, Wolters Kluwer Health

    Professor Deepak L Bhatt

  109. Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease

    Article • JAMA Cardiology, June 2024, American Medical Association (AMA)

    Professor Deepak L Bhatt

  110. Intravascular lithotripsy compared with rotational atherectomy for calcified coronary lesions: A meta-analysis of outcomes

    Article • Cardiovascular Revascularization Medicine, June 2024, Elsevier

    Professor Deepak L Bhatt

  111. Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction

    Article • Journal of the American College of Cardiology, June 2024, Elsevier

    Professor Deepak L Bhatt

  112. Pathophysiology of Preeclampsia-Induced Vascular Dysfunction and Implications for Subclinical Myocardial Damage and Heart Failure

    Article • JACC Advances, June 2024, Elsevier

    Professor Deepak L Bhatt

  113. Procedural Volume and Outcomes in Lower Extremity Peripheral Vascular Interventions: Insights from the National Cardiovascular Data Registry Peripheral Vascular Intervention Registry

    Article • May 2024, Cold Spring Harbor Laboratory Press

    Professor Deepak L Bhatt

  114. Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) Registry

    Article • Journal of the American Heart Association, May 2024, Wolters Kluwer Health

    Professor Deepak L Bhatt

  115. Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial

    Article • Circulation, May 2024, Wolters Kluwer Health

    Professor Deepak L Bhatt

  116. Moderate Aortic Valve Stenosis Is Associated With Increased Mortality Rate and Lifetime Loss: Systematic Review and Meta‐Analysis of Reconstructed Time‐to‐Event Data of 409 680 Patients

    Article • Journal of the American Heart Association, May 2024, Wolters Kluwer Health

    Professor Deepak L Bhatt

  117. Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 2024, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt

  118. One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes

    Article • EuroIntervention, May 2024, Europa Digital & Publishing

    Professor Deepak L Bhatt

  119. Outcomes by sex in the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial

    Article • EuroIntervention, May 2024, Europa Digital & Publishing

    Professor Deepak L Bhatt

  120. The ROMA trial: 7 years of trial activities and the development of the ROMA trial network

    Article • European Journal of Cardio-Thoracic Surgery, May 2024, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  121. Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, April 2024, Oxford University Press (OUP)

    Dr Dimitar Sajkov, Professor Deepak L Bhatt

  122. Empagliflozin after Acute Myocardial Infarction

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2024, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt

  123. Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, April 2024, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  124. Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk‐Enriched Rheumatoid Arthritis Patients

    Article • Arthritis & Rheumatology, April 2024, Wiley

    Professor Deepak L Bhatt

  125. Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography

    Article • European Heart Journal, April 2024, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  126. Reply to ‘The pharmacist ally in heart failure: Useful when involved’

    Article • European Journal of Heart Failure, April 2024, Wiley

    Professor Deepak L Bhatt

  127. Feasibility and Findings of Including Self-Identified Adult Congenital Heart Disease Patients in the INVESTED Trial

    Article • JACC Advances, April 2024, Elsevier

    Professor Deepak L Bhatt

  128. Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis

    Article • Journal of the American College of Cardiology, April 2024, Elsevier

    Professor Deepak L Bhatt

  129. Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl

    Article • Journal of the American College of Cardiology, April 2024, Elsevier

    Professor Deepak L Bhatt

  130. Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations

    Article • JAMA Cardiology, April 2024, American Medical Association (AMA)

    Professor Deepak L Bhatt

  131. Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort study

    Article • The Lancet Regional Health - Europe, April 2024, Elsevier

    Professor Deepak L Bhatt

  132. Non-coronary peripheral arterial complications in people with type 2 diabetes: a Swedish retrospective cohort study

    Article • The Lancet Regional Health - Europe, April 2024, Elsevier

    Professor Deepak L Bhatt

  133. Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic Stenosis

    Article • JAMA Cardiology, April 2024, American Medical Association (AMA)

    Professor Deepak L Bhatt

  134. Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study

    Article • RMD Open, April 2024, BMJ

    Professor Deepak L Bhatt

  135. Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage

    Article • JAMA Neurology, April 2024, American Medical Association (AMA)

    Professor Deepak L Bhatt

  136. Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial

    Article • European Journal of Heart Failure, April 2024, Wiley

    Professor Deepak L Bhatt

  137. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease

    Article • Nature Reviews Cardiology, March 2024, Springer Science + Business Media

    Professor Deepak L Bhatt

  138. Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES

    Article • European Journal of Preventive Cardiology, March 2024, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  139. Net clinical benefit of extended dual pathway inhibition according to baseline risk in patients with chronic coronary syndrome: a COMPASS substudy

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, March 2024, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  140. Author Correction: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial

    Article • Nature Reports Stem Cells, March 2024, Springer Science + Business Media

    Professor Deepak L Bhatt

  141. One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial

    Article • EuroIntervention, March 2024, Europa Digital & Publishing

    Professor Venugopal Rao Soma, Professor Deepak L Bhatt

  142. 1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global Program

    Article • The American Journal of Cardiology, March 2024, Elsevier

    Professor Deepak L Bhatt

  143. Aldosterone and aldosterone synthase inhibitors in cardiorenal disease

    Article • AJP Heart and Circulatory Physiology, March 2024, American Physiological Society

    Professor Deepak L Bhatt

  144. Coronary artery bypass grafting versus medical therapy in patients with stable coronary artery disease: An individual patient data pooled meta-analysis of randomized trials

    Article • Journal of Thoracic and Cardiovascular Surgery, March 2024, Elsevier

    Professor Deepak L Bhatt

  145. Inflammation, infection, and cardiovascular risk – Authors' reply

    Article • The Lancet, March 2024, Elsevier

    Professor Deepak L Bhatt

  146. Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease

    Article • Journal of the American College of Cardiology, March 2024, Elsevier

    Professor Deepak L Bhatt

  147. The Legends Colloquium

    Article • Journal of the American College of Cardiology, March 2024, Elsevier

    Professor Deepak L Bhatt

  148. Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials

    Article • European Heart Journal, February 2024, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  149. Artificial Intelligence-Based Automated Interpretation of Images of Electrocardiograms: Development and Multinational Validation of ECG-GPT

    Article • February 2024, Cold Spring Harbor Laboratory Press

    Professor Deepak L Bhatt

  150. The Canadian Cardiovascular Society Classification of acute atherothrombotic myocardial infarction provides a novel staging scheme based on tissue injury severity

    Article • European Heart Journal, February 2024, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  151. A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty Acids

    Article • Cardiovascular Drugs and Therapy, February 2024, Springer Science + Business Media

    Professor Deepak L Bhatt

  152. Impact of the 2021 European Society for Cardiology prevention guideline’s stepwise approach for cardiovascular risk factor treatment in patients with established atherosclerotic cardiovascular disease

    Article • European Journal of Preventive Cardiology, February 2024, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  153. Trends in Stroke Thrombolysis Care Metrics and Outcomes by Race and Ethnicity, 2003-2021

    Article • JAMA Network Open, February 2024, American Medical Association (AMA)

    Professor Deepak L Bhatt

  154. European Association of Cardio-Thoracic Surgery (EACTS) expert consensus statement on perioperative myocardial infarction after cardiac surgery

    Article • European Journal of Cardio-Thoracic Surgery, February 2024, Oxford University Press (OUP)

    Prof. Giuseppe Biondi-Zoccai, Professor Deepak L Bhatt

  155. Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial

    Article • Nature Reports Stem Cells, February 2024, Springer Science + Business Media

    Professor Deepak L Bhatt

  156. Risk of Bleeding Among Cangrelor-Treated Patients Administered Upstream P2Y12 Inhibitor Therapy: The CAMEO Registry

    Article • Journal of the Society for Cardiovascular Angiography & Interventions, February 2024, Elsevier

    Professor Deepak L Bhatt

  157. Vascular Regenerative Cell Deficiencies in South Asian Adults

    Article • Journal of the American College of Cardiology, February 2024, Elsevier

    Professor Deepak L Bhatt

  158. Sotagliflozin and Kidney Outcomes, Kidney Function, and Albuminuria in Type 2 Diabetes and CKD

    Article • Clinical Journal of the American Society of Nephrology, January 2024, Wolters Kluwer Health

    Professor Deepak L Bhatt

  159. Enhancing Atrial Fibrillation Prediction Using Multimodal Neural Networks and XGBoost Integration

    Article • January 2024, Research Square

    Professor Deepak L Bhatt

  160. Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial

    Article • European Heart Journal, January 2024, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  161. Exposome in ischaemic heart disease: beyond traditional risk factors

    Article • European Heart Journal, January 2024, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  162. Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests

    Article • Circulation, January 2024, Wolters Kluwer Health

    Professor Deepak L Bhatt

  163. Natriuretic peptides, body mass index and heart failure risk: Pooled analyses of SAVOR‐TIMI 53, DECLARE‐TIMI 58 and CAMELLIA‐TIMI 61

    Article • European Journal of Heart Failure, January 2024, Wiley

    Professor Deepak L Bhatt

  164. Omega-3 fatty acids for cardiovascular event lowering

    Article • European Journal of Preventive Cardiology, January 2024, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  165. Cost‐Effectiveness of Icosapent Ethyl in REDUCE‐IT USA: Results From Patients Randomized in the United States

    Article • Journal of the American Heart Association, January 2024, Wolters Kluwer Health

    Professor Deepak L Bhatt

  166. 1+2 Might Be >2

    Article • JACC Heart Failure, January 2024, Elsevier

    Professor Deepak L Bhatt

  167. CS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial

    Article • Pulmonary Circulation, January 2024, Wiley

    Professor Deepak L Bhatt

  168. Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics

    Article • American Heart Journal, January 2024, Elsevier

    Professor Deepak L Bhatt

  169. Effective medications can work only in patients who take them: Implications for post‐acute heart failure care

    Article • European Journal of Heart Failure, January 2024, Wiley

    Professor Deepak L Bhatt

  170. Promise of a Novel Classification System for Acute Myocardial Infarction

    Article • Canadian Journal of Cardiology, January 2024, Elsevier

    Professor Deepak L Bhatt

  171. SGLT2 Inhibitors in Patients With Cancer Therapy-Related Cardiotoxicity

    Article • JACC Heart Failure, January 2024, Elsevier

    Professor Deepak L Bhatt

  172. Trends and Outcomes of Acute Myocardial Infarction During the Early COVID-19 Pandemic in the United States: A National Inpatient Sample Study

    Article • Korean Circulation Journal, January 2024, XMLink

    Professor Deepak L Bhatt

  173. The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective

    Article • American Journal of Cardiovascular Drugs, December 2023, Springer Science + Business Media

    Professor Deepak L Bhatt

  174. Epeleuton, a novel synthetic ω-3 fatty acid, reduces the hypoxia/reperfusion stress in a mouse model of sickle cell disease

    Article • Haematologica, December 2023, Ferrata Storti Foundation (Haematologica)

    Professor Deepak L Bhatt

  175. Ticagrelor or prasugrel vs. clopidogrel in patients with atrial fibrillation undergoing percutaneous coronary intervention for myocardial infarction

    Article • European Heart Journal Open, December 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  176. Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial

    Article • Nature Reports Stem Cells, December 2023, Springer Science + Business Media

    Professor Deepak L Bhatt

  177. Serial troponin-I and long-term outcomes in subjects with suspected acute coronary syndrome

    Article • European Journal of Preventive Cardiology, December 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  178. Antithrombotic and Statin Prescription After Intracerebral Hemorrhage in the Get With The Guidelines-Stroke Registry

    Article • Stroke, December 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  179. Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial

    Article • The Lancet Diabetes & Endocrinology, December 2023, Elsevier

    Professor Deepak L Bhatt

  180. Comparison of Intravascular Imaging, Functional, or Angiographically Guided Coronary Intervention

    Article • Journal of the American College of Cardiology, December 2023, Elsevier

    Professor Deepak L Bhatt

  181. Do patients benefit from omega-3 fatty acids?

    Article • Cardiovascular Research, December 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  182. Reporting Extended Follow-Up in Cardiovascular Clinical Trials

    Article • Journal of the American College of Cardiology, December 2023, Elsevier

    Professor Deepak L Bhatt

  183. The NCDR’s Chest Pain Myocardial Infarction Registry

    Article • JACC Advances, December 2023, Elsevier

    Professor Deepak L Bhatt

  184. An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trials

    Article • npj Digital Medicine, November 2023, Springer Science + Business Media

    Professor Deepak L Bhatt

  185. Higher Procedural Volumes Are Associated with Faster Treatment Times, Better Functional Outcomes, and Lower Mortality in Patients Undergoing Endovascular Treatment for Acute Ischemic Stroke

    Article • Annals of Neurology, November 2023, Wiley

    Professor Deepak L Bhatt

  186. Endpoint adjudication in cardiovascular clinical trials

    Article • European Heart Journal, November 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  187. Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial

    Article • Journal of the American College of Cardiology, November 2023, Elsevier

    Prof. Giuseppe Biondi-Zoccai, Professor Deepak L Bhatt

  188. Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping Review

    Article • Clinical Therapeutics, November 2023, Elsevier

    Gerald Chi, Professor Deepak L Bhatt

  189. Effectiveness of icosapent ethyl on first and total cardiovascular events in patients with metabolic syndrome, but without diabetes: REDUCE-IT MetSyn

    Article • European Heart Journal Open, November 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  190. Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline Hemoglobin A1c

    Article • Journal of the American College of Cardiology, November 2023, Elsevier

    Professor Deepak L Bhatt

  191. Lipoprotein(a) and Benefit of Antiplatelet Therapy

    Article • JACC Advances, November 2023, Elsevier

    Professor Deepak L Bhatt

  192. Primary Prevention of Subclinical Atherosclerosis in Young Adults

    Article • Journal of the American College of Cardiology, November 2023, Elsevier

    Professor Deepak L Bhatt

  193. Icosapent ethyl for hypertriglyceridaemia and atherosclerosis: greater RESPECT for increased therapeutic use

    Article • European Heart Journal, October 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  194. Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up

    Article • Circulation, October 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  195. Personalized Medicine for Cardiovascular Disease Risk in Artificial Intelligence Framework

    Article • October 2023, Research Square

    Professor Deepak L Bhatt

  196. Changes in physical activity and incident cardiovascular events in cancer survivors

    Article • European Heart Journal, October 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  197. 1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI

    Article • JACC Cardiovascular Interventions, October 2023, Elsevier

    Professor Deepak L Bhatt

  198. Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions

    Article • JACC Cardiovascular Interventions, October 2023, Elsevier

    Professor Deepak L Bhatt

  199. Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer

    Article • JACC CardioOncology, October 2023, Elsevier

    Professor Deepak L Bhatt

  200. Lipoprotein(a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome

    Article • Canadian Journal of Cardiology, October 2023, Elsevier

    Professor Deepak L Bhatt

  201. Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study

    Article • The Lancet, October 2023, Elsevier

    Professor Deepak L Bhatt

  202. Recurrent Events in Cardiovascular Trials

    Article • Journal of the American College of Cardiology, October 2023, Elsevier

    Professor Deepak L Bhatt

  203. Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial

    Article • Journal of the American Heart Association, September 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  204. Pre-arterialization of coronary veins prior to retroperfusion of ischemic myocardium: percutaneous closure device

    Article • Frontiers in Cardiovascular Medicine, September 2023, Frontiers

    Professor Deepak L Bhatt

  205. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2023, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt

  206. Temporal Association Among Influenza-Like Illness, Cardiovascular Events, and Vaccine Dose in Patients With High-Risk Cardiovascular Disease

    Article • JAMA Network Open, September 2023, American Medical Association (AMA)

    Professor Deepak L Bhatt

  207. Utility of rapid atrial pacing before and after TAVR with balloon‐expandable valve in  predicting permanent pacemaker implantation

    Article • Catheterization and Cardiovascular Interventions, September 2023, Wiley

    Professor Deepak L Bhatt

  208. Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction

    Article • European Heart Journal, September 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  209. Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors

    Article • Journal of the American College of Cardiology, September 2023, Elsevier

    Professor Deepak L Bhatt

  210. Development and validation of a predictive model for the diagnosis of rheumatic heart disease in low-income countries based on two cross-sectional studies

    Article • International Journal of Cardiology Cardiovascular Risk and Prevention, September 2023, Elsevier

    Professor Deepak L Bhatt

  211. Generalizability of REDUCE-IT eligibility criteria in a large diabetes cardiovascular outcomes trial: A post hoc subgroup analysis of EMPA-REG outcome

    Article • American Journal of Preventive Cardiology, September 2023, Elsevier

    Professor Deepak L Bhatt

  212. Public reporting for coronary artery bypass graft surgery: The quest for the optimal scorecard

    Article • Journal of Thoracic and Cardiovascular Surgery, September 2023, Elsevier

    Professor Deepak L Bhatt

  213. Short-Term DAPT and DAPT De-Escalation Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

    Article • Circulation Cardiovascular Interventions, September 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  214. Successful Endovascular Treatment of an Anastomotic Pseudoaneurysm in the Ascending Aorta

    Article • The American Journal of Cardiology, September 2023, Elsevier

    Professor Deepak L Bhatt

  215. The relationship between mortality and daily number of steps in type 2 diabetes

    Article • Panminerva Medica, September 2023, Edizioni Minerva Medica

    Professor Deepak L Bhatt

  216. Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future Directions

    Article • Journal of Clinical Medicine, August 2023, MDPI AG

    Prof. Giuseppe Biondi-Zoccai, Professor Deepak L Bhatt

  217. Heart failure medical therapy prior to mitral transcatheter edge-to-edge repair: the STS/ACC Transcatheter Valve Therapy Registry

    Article • European Heart Journal, August 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  218. Baseline characteristics of patients enrolled in the EMPACT‐MI trial

    Article • European Journal of Heart Failure, August 2023, Wiley

    Professor Deepak L Bhatt

  219. Pleiotropic Effects of Influenza Vaccination

    Article • Vaccines, August 2023, MDPI AG

    Professor Deepak L Bhatt

  220. Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes

    Article • Diabetes Care, August 2023, American Diabetes Association

    Professor Deepak L Bhatt

  221. Left-sided valvular heart disease and survival in out-of-hospital cardiac arrest: a nationwide registry-based study

    Article • Scientific Reports, August 2023, Springer Science + Business Media

    Professor Deepak L Bhatt

  222. Quantitative imaging biomarkers of coronary plaque morphology: insights from EVAPORATE

    Article • Frontiers in Cardiovascular Medicine, August 2023, Frontiers

    Professor Deepak L Bhatt

  223. Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events

    Article • JACC Heart Failure, August 2023, Elsevier

    Professor Deepak L Bhatt

  224. Predicting and preventing heart failure in type 2 diabetes

    Article • The Lancet Diabetes & Endocrinology, August 2023, Elsevier

    Professor Deepak L Bhatt

  225. Early versus delayed coronary angiography in patients with out-of-hospital cardiac arrest and no ST-segment elevation: a systematic review and meta-analysis of randomized controlled trials

    Article • Clinical Research in Cardiology, July 2023, Springer Science + Business Media

    Professor Deepak L Bhatt

  226. Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease

    Article • Diabetes Obesity and Metabolism, July 2023, Wiley

    Professor Deepak L Bhatt

  227. GRACE scores or high-sensitivity troponin for timing of coronary angiography in non-ST-elevation acute coronary syndromes

    Article • Clinical Research in Cardiology, July 2023, Springer Science + Business Media

    Professor Deepak L Bhatt

  228. Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease

    Article • European Journal of Preventive Cardiology, July 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  229. Mortality in Patients Hospitalized With Acute Myocardial Infarction Without Standard Modifiable Risk Factors: The ARIC Study Community Surveillance

    Article • Journal of the American Heart Association, July 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  230. Shorter Door-to-Needle Times Are Associated With Better Outcomes After Intravenous Thrombolytic Therapy and Endovascular Thrombectomy for Acute Ischemic Stroke

    Article • Circulation, July 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  231. Low-Density Lipoprotein Cholesterol Levels in Adults With Coronary Artery Disease in the US, January 2015 to March 2020

    Article • JAMA, July 2023, American Medical Association (AMA)

    Professor Deepak L Bhatt

  232. Dual pathway inhibition in atherothrombosis prevention: yes, now we can!

    Article • Minerva Cardiology and Angiology, July 2023, Edizioni Minerva Medica

    Prof. Giuseppe Biondi-Zoccai, Professor Deepak L Bhatt

  233. Cardiovascular outcomes in patients with coronary artery disease and elevated lipoprotein(a): implications for the OCEAN(a)-outcomes trial population

    Article • European Heart Journal Open, July 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  234. Corrigendum to ‘Integrating Coronary Atherosclerosis Burden and Progression with Coronary Artery Disease Risk Factors to Guide Therapeutic Decision Making’ The American Journal of Medicine 136:03 (2023); 260-269.e7

    Article • The American Journal of Medicine, July 2023, Elsevier

    Professor Deepak L Bhatt

  235. Mid-Term Outcomes of TAVR in Intermediate-Risk Patients

    Article • Journal of the American College of Cardiology, July 2023, Elsevier

    Professor Deepak L Bhatt

  236. P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events

    Article • Journal of the American College of Cardiology, July 2023, Elsevier

    Professor Deepak L Bhatt

  237. The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial

    Article • Nature Reports Stem Cells, June 2023, Springer Science + Business Media

    Professor Deepak L Bhatt

  238. An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized controlled trials

    Article • June 2023, Cold Spring Harbor Laboratory Press

    Professor Deepak L Bhatt

  239. Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium

    Article • Circulation, June 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  240. Recent Vitamin K Antagonist Use and Intracranial Hemorrhage After Endovascular Thrombectomy for Acute Ischemic Stroke

    Article • JAMA, June 2023, American Medical Association (AMA)

    Professor Deepak L Bhatt

  241. Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study

    Article • Circulation, June 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  242. Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry

    Article • Clinical Research in Cardiology, June 2023, Springer Science + Business Media

    Professor Deepak L Bhatt

  243. Large and small peripheral arterial disease in persons with type 2 diabetes

    Article • June 2023, Cold Spring Harbor Laboratory Press

    Professor Deepak L Bhatt

  244. Smoking habit change after cancer diagnosis: effect on cardiovascular risk

    Article • European Heart Journal, June 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  245. A Comparison of COVID-19 and Influenza in Heart Transplant Recipients: A Nationwide Study in the United States

    Article • Canadian Journal of Cardiology, June 2023, Elsevier

    Professor Deepak L Bhatt

  246. Assessment of Atherothrombotic Risk in Patients With Type 2 Diabetes Mellitus

    Article • Journal of the American College of Cardiology, June 2023, Elsevier

    Professor Deepak L Bhatt

  247. Clinical Profiles, Outcomes, and Sex Differences of Patients With STEMI

    Article • JACC Asia, June 2023, Elsevier

    Professor Deepak L Bhatt

  248. Effect of COVID-19 Infection in Patients Who Present With Acute Myocardial Infarction and Cardiogenic Shock

    Article • Canadian Journal of Cardiology, June 2023, Elsevier

    Professor Deepak L Bhatt

  249. Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations

    Article • Journal of the American College of Cardiology, June 2023, Elsevier

    Professor Deepak L Bhatt

  250. Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution

    Article • Biomedicine & Pharmacotherapy, June 2023, Elsevier

    Professor Deepak L Bhatt

  251. Individuals With Chronic Kidney Disease Qualifying for SGLT-2 Inhibitors in the United States and EMPA-KIDNEY Generalizability

    Article • JACC Advances, June 2023, Elsevier

    Professor Deepak L Bhatt

  252. Transcatheter Mitral Valve Repair for Degenerative Mitral Regurgitation

    Article • JAMA, May 2023, American Medical Association (AMA)

    Professor Deepak L Bhatt

  253. Mortality trends of aortic stenosis in high-income countries from 2000 to 2020

    Article • Heart, May 2023, BMJ

    Professor Deepak L Bhatt

  254. New approaches to reduce recurrent PCI: to angioplasty and beyond!

    Article • European Heart Journal Open, May 2023, Oxford University Press (OUP)

    Prof. Giuseppe Biondi-Zoccai, Professor Deepak L Bhatt

  255. Impact of Diabetes on Outcomes in Patients Hospitalized With Acute Myocardial Infarction: Insights From the Atherosclerosis Risk in Communities Study Community Surveillance

    Article • Journal of the American Heart Association, May 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  256. It’s (not just) the cholesterol, stupid! Recent lessons about chronic inflammation and cardiovascular risk

    Article • European Journal of Preventive Cardiology, May 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  257. Semaglutide reduces the risk of major adverse cardiovascular events consistently across baseline triglyceride levels in patients with type 2 diabetes: Post hoc analyses of the SUSTAIN 6 and PIONEER 6 trials

    Article • Diabetes Obesity and Metabolism, May 2023, Wiley

    Professor Deepak L Bhatt

  258. Assessment of Nonfatal Bleeding Events as a Surrogate for Mortality in Coronary Artery Disease

    Article • JACC Advances, May 2023, Elsevier

    Professor Deepak L Bhatt

  259. Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes

    Article • JAMA Cardiology, May 2023, American Medical Association (AMA)

    Professor Deepak L Bhatt

  260. Pegozafermin for the Treatment of Severe Hypertriglyceridemia: A Randomized, Double-blind, Placebo-controlled Phase 2 Study (ENTRIGUE STUDY)

    Article • Metabolism, May 2023, Elsevier

    Professor Deepak L Bhatt

  261. Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19

    Article • Journal of the American College of Cardiology, May 2023, Elsevier

    Professor Deepak L Bhatt

  262. Same-Day Discharge after Percutaneous Left Atrial Appendage Closure: Insights from the Nationwide Readmission Database 2015-2019

    Article • Current Problems in Cardiology, May 2023, Elsevier

    Professor Deepak L Bhatt

  263. Clinical and Pre-Clinical Pharmacokinetics and Pharmacodynamics of Bentracimab

    Article • Clinical Pharmacokinetics, April 2023, Springer Science + Business Media

    Professor Deepak L Bhatt

  264. Benefit of icosapent ethyl on coronary physiology assessed by computed tomography angiography fractional flow reserve: EVAPORATE-FFRCT

    Article • European Heart Journal - Cardiovascular Imaging, April 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  265. Dietary intake and cardiovascular outcomes in patients with chronic vascular disease: insights from the COMPASS trial cohort

    Article • European Journal of Preventive Cardiology, April 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  266. Comparative Effects of Mineral Oil, Corn Oil, Eicosapentaenoic Acid, and Docosahexaenoic Acid in an In Vitro Atherosclerosis Model

    Article • Journal of the American Heart Association, April 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  267. Correlation Between Periprocedural Myocardial Infarction, Mortality, and Quality of Life in Coronary Revascularization Trials: A Meta-analysis

    Article • Journal of the Society for Cardiovascular Angiography & Interventions, April 2023, Elsevier

    Prof. Giuseppe Biondi-Zoccai, Professor Deepak L Bhatt

  268. Editorial commentary: Weight loss for cardiovascular disease prevention – is semaglutide the answer?

    Article • Trends in Cardiovascular Medicine, April 2023, Elsevier

    Professor Deepak L Bhatt

  269. Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial

    Article • The Lancet Diabetes & Endocrinology, April 2023, Elsevier

    Professor Deepak L Bhatt

  270. Evaluating national guideline concordance of recurrent interventions after radiocephalic arteriovenous fistula creation

    Article • Journal of Vascular Surgery, April 2023, Elsevier

    Professor Deepak L Bhatt

  271. Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme

    Article • Annals of the Rheumatic Diseases, April 2023, Elsevier

    Professor Deepak L Bhatt

  272. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials

    Article • The Lancet, April 2023, Elsevier

    Professor Deepak L Bhatt

  273. Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes

    Article • Vascular Pharmacology, April 2023, Elsevier

    Professor Deepak L Bhatt

  274. Key questions regarding the SYMPLICITY HTN-3 trial – Authors' reply

    Article • The Lancet, April 2023, Elsevier

    Professor Deepak L Bhatt

  275. Myocardial Perfusion PET for the Detection and Reporting of Coronary Microvascular Dysfunction

    Article • JACC Cardiovascular Imaging, April 2023, Elsevier

    Professor Deepak L Bhatt

  276. The Association Between Beta-blocker and Renin–Angiotensin System Inhibitor Use After Heart Failure With Reduced Ejection Fraction Hospitalization and Outcomes in Older Patients

    Article • Journal of Cardiac Failure, April 2023, Elsevier

    Professor Deepak L Bhatt

  277. Time to Benefit With Sotagliflozin in Patients With Worsening Heart Failure

    Article • Journal of the American College of Cardiology, April 2023, Elsevier

    Professor Deepak L Bhatt

  278. Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial

    Article • American Heart Journal, April 2023, Elsevier

    Professor Deepak L Bhatt

  279. Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding

    Article • European Heart Journal, March 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  280. Intensity of Lipid-Lowering Therapy Among Patients With Polyvascular Disease

    Article • JAMA Network Open, March 2023, American Medical Association (AMA)

    Professor Deepak L Bhatt

  281. Efficacy of sodium–glucose cotransporter 2 inhibitors and angiotensin receptor–neprilysin inhibitors for heart failure in black patients: a systematic review and meta‐analysis of randomized controlled trials

    Article • European Journal of Heart Failure, March 2023, Wiley

    Professor Deepak L Bhatt

  282. Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE‐IT

    Article • Journal of the American Heart Association, March 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  283. Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study

    Article • Diabetes Obesity and Metabolism, March 2023, Wiley

    Professor Deepak L Bhatt

  284. Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

    Article • European Heart Journal, March 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  285. Comparing benefits from sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in randomized clinical trials: a network meta-analysis

    Article • Minerva Cardiology and Angiology, March 2023, Edizioni Minerva Medica

    Professor Deepak L Bhatt

  286. Integrating Coronary Atherosclerosis Burden and Progression with Coronary Artery Disease Risk Factors to Guide Therapeutic Decision Making

    Article • The American Journal of Medicine, March 2023, Elsevier

    Professor Deepak L Bhatt

  287. Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial

    Article • Annals of the Rheumatic Diseases, March 2023, Elsevier

    Professor Deepak L Bhatt

  288. Mechanical Circulatory Support Devices in Acute Myocardial Infarction-Cardiogenic Shock: Current Studies and Future Directions

    Article • Journal of the Society for Cardiovascular Angiography & Interventions, March 2023, Elsevier

    Professor Deepak L Bhatt

  289. ONE- VERSUS THREE-MONTH DAPT IN OLDER PATIENTS AT HIGH BLEEDING RISK UNDERGOING PCI: INSIGHTS FROM THE XIENCE SHORT DAPT GLOBAL PROGRAM

    Article • Journal of the American College of Cardiology, March 2023, Elsevier

    Professor Deepak L Bhatt

  290. Outcomes After Transcatheter Aortic Valve Implantation in Patients Excluded From Clinical Trials

    Article • JACC Advances, March 2023, Elsevier

    Professor Deepak L Bhatt

  291. Predicting survival and neurological outcome in out-of-hospital cardiac arrest using machine learning: the SCARS model

    Article • EBioMedicine, March 2023, Elsevier

    Professor Deepak L Bhatt

  292. Trends in Blood Pressure Treatment Intensification in Older Adults With Hypertension in the United States, 2008 to 2018

    Article • Hypertension, March 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  293. Abstract P567: Cardiovascular Health Awareness and Risk Assessment in Schoolteachers in Calcutta, India

    Article • Circulation, February 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  294. Age period cohort analysis of rheumatic heart disease in high-income countries

    Article • Clinical Research in Cardiology, February 2023, Springer Science + Business Media

    Professor Deepak L Bhatt

  295. Pulling Out All the Stops: A Case of Progressive Dyspnea

    Article • Circulation, February 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  296. Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease

    Article • Diabetes Obesity and Metabolism, February 2023, Wiley

    James Mancuso, Professor Deepak L Bhatt

  297. Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, February 2023, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt

  298. Assessing Heuristic Bias During Care for Patients Hospitalized for Heart Failure: Get With The Guidelines-Heart Failure

    Article • Circulation Heart Failure, February 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  299. Combined Minimally Invasive Surgical and Percutaneous Catheter Ablation of Atrial Fibrillation

    Article • Journal of the American College of Cardiology, February 2023, Elsevier

    Professor Deepak L Bhatt

  300. Generalizability of the REDUCE-IT trial to South Asians with cardiovascular disease

    Article • Med, February 2023, Elsevier

    Professor Deepak L Bhatt

  301. Optimal Antiplatelet Therapy Revisited

    Article • Journal of the American College of Cardiology, February 2023, Elsevier

    Professor Deepak L Bhatt

  302. Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish heart failure registry

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, January 2023, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  303. Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial

    Article • Circulation, January 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  304. Cardiac arrhythmias and conduction abnormalities in patients with type 2 diabetes

    Article • Scientific Reports, January 2023, Springer Science + Business Media

    Professor Deepak L Bhatt

  305. Utilization and Outcomes of Clinically Indicated Invasive Cardiac Care in Veterans with Acute Coronary Syndrome and Chronic Kidney Disease

    Article • Journal of the American Society of Nephrology, January 2023, Wolters Kluwer Health

    Professor Deepak L Bhatt

  306. Outcomes of Prediabetes Compared with Normoglycaemia and Diabetes Mellitus in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis

    Article • Heart International, January 2023, Touch Digital Media, Ltd.

    Professor Jolanta M Siller-Matula, Professor Deepak L Bhatt

  307. External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued ...

    Article • International Journal of Cardiology, January 2023, Elsevier

    Prof HECTOR BUENO, Professor Deepak L Bhatt

  308. A Message From the Next Generations

    Article • JACC Advances, January 2023, Elsevier

    Professor Deepak L Bhatt

  309. A global view on the incidence and mortality of infective endocarditis

    Article • International Journal of Cardiology, January 2023, Elsevier

    Professor Deepak L Bhatt

  310. Large and Small Peripheral Arterial Disease in Persons with Type 2 Diabetes

    Article • January 2023, Elsevier

    Professor Deepak L Bhatt

  311. Mortality and Heart Failure Hospitalization Among Young Adults With and Without Cardiogenic Shock After Acute Myocardial Infarction

    Article • Journal of Cardiac Failure, January 2023, Elsevier

    Professor Deepak L Bhatt

  312. Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance

    Article • Therapeutic Advances in Musculoskeletal Disease, January 2023, SAGE Publications

    Professor Deepak L Bhatt

  313. Significant Myocardial Infarct Reductions Via Isolated Coronary Sinus Cooling: A Delayed Reperfusion Pilot Preclinical Study

    Article • SSRN Electronic Journal, January 2023, Elsevier

    Professor Deepak L Bhatt

  314. Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance

    Article • Annals of the Rheumatic Diseases, January 2023, Elsevier

    Professor Deepak L Bhatt

  315. Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues

    Article • Current Atherosclerosis Reports, December 2022, Springer Science + Business Media

    Professor Deepak L Bhatt

  316. Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials

    Article • European Heart Journal, December 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  317. Early initiation of PCSK9 inhibition in myocardial infarction could be EPIC for patient care

    Article • EuroIntervention, December 2022, Europa Digital & Publishing

    Professor Deepak L Bhatt

  318. Efficacy of supermarket and web-based interventions for improving dietary quality: a randomized, controlled trial

    Article • Nature Reports Stem Cells, December 2022, Springer Science + Business Media

    Professor Deepak L Bhatt

  319. Elevated C-Reactive Protein Amplifies Association of Lipoprotein(a) With Cardiovascular Risk and Clinical Benefit of Alirocumab

    Article • Journal of the American College of Cardiology, December 2022, Elsevier

    Professor Deepak L Bhatt

  320. Major Adverse Cardiovascular Events Across the Sotagliflozin Clinical Development Program

    Article • American Heart Journal, December 2022, Elsevier

    Professor Deepak L Bhatt

  321. Variation in Survival After Cardiopulmonary Arrest in Cardiac Catheterization Laboratories in the United States

    Article • JACC Cardiovascular Interventions, December 2022, Elsevier

    Professor Deepak L Bhatt

  322. Health status and cognitive function for risk stratification in chronic coronary and peripheral artery disease

    Article • European Journal of Preventive Cardiology, November 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  323. Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events

    Article • JAMA Network Open, November 2022, American Medical Association (AMA)

    Professor Deepak L Bhatt

  324. Efficacy and Safety of Dapagliflozin by Baseline Insulin Regimen and Dose: Post Hoc Analyses From DECLARE-TIMI 58

    Article • Diabetes Care, November 2022, American Diabetes Association

    Professor Deepak L Bhatt

  325. Palliative Care Utilization Among Hospitalized Patients With Common Chronic Conditions in the United States

    Article • Journal of Palliative Care, November 2022, SAGE Publications

    Professor Deepak L Bhatt

  326. Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54

    Article • European Heart Journal, November 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  327. Hypertension management in patients with cardiovascular comorbidities

    Article • European Heart Journal, November 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  328. Association of post‐vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high‐risk cardiovascular disease: the INVESTED trial

    Article • European Journal of Heart Failure, November 2022, Wiley

    Professor Deepak L Bhatt

  329. Serial troponin-T and long-term outcomes in suspected acute coronary syndrome

    Article • European Heart Journal, November 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  330. Increased residual cardiovascular risk in U.S. veterans with moderately-elevated baseline triglycerides and well-controlled LDL-C levels on statins

    Article • Frontiers in Cardiovascular Medicine, November 2022, Frontiers

    Professor Deepak L Bhatt

  331. A randomized trial comparing axillary versus innominate artery cannulation for aortic arch surgery

    Article • Journal of Thoracic and Cardiovascular Surgery, November 2022, Elsevier

    Professor Deepak L Bhatt

  332. Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial

    Article • American Heart Journal, November 2022, Elsevier

    Professor Deepak L Bhatt

  333. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

    Article • The Lancet, November 2022, Elsevier

    Professor Deepak L Bhatt

  334. Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial

    Article • Annals of the Rheumatic Diseases, November 2022, Elsevier

    Professor Deepak L Bhatt

  335. One size fits all: The story of SGLT2 inhibitors in heart failure

    Article • Med, November 2022, Elsevier

    Professor Deepak L Bhatt

  336. The Rise and Fall and Rise of Renal Denervation

    Article • Journal of the American College of Cardiology, November 2022, Elsevier

    Professor Deepak L Bhatt

  337. Predicting radiocephalic arteriovenous fistula success with machine learning

    Article • npj Digital Medicine, October 2022, Springer Science + Business Media

    Professor Deepak L Bhatt

  338. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

    Article • Circulation, October 2022, Wolters Kluwer Health

    Prof HECTOR BUENO, Professor Deepak L Bhatt

  339. Corrigendum to: Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, October 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  340. Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the Nationwide Inpatient Sample and Nationwide Readmission Database

    Article • Catheterization and Cardiovascular Interventions, October 2022, Wiley

    Professor Deepak L Bhatt

  341. Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES

    Article • Canadian Journal of Cardiology, October 2022, Elsevier

    Professor Deepak L Bhatt

  342. Case‐fatality rate of major bleeding events in patients on dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta‐analysis

    Article • Research and Practice in Thrombosis and Haemostasis, October 2022, Elsevier

    Professor Deepak L Bhatt

  343. EPA Versus Mixed EPA/DHA Plus Statin for Coronary Atherosclerosis

    Article • JACC Cardiovascular Imaging, October 2022, Elsevier

    Professor Deepak L Bhatt

  344. Evaluating the Application of Chronic Heart Failure Therapies and Developing Treatments in Individuals With Recent Myocardial Infarction

    Article • JAMA Cardiology, October 2022, American Medical Association (AMA)

    Professor Deepak L Bhatt

  345. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

    Article • The Lancet, October 2022, Elsevier

    Professor Deepak L Bhatt

  346. SGLT2 Inhibitors Are Lifesavers in Heart Failure

    Article • Heart Failure Clinics, October 2022, Elsevier

    Professor Deepak L Bhatt

  347. Contemporary National Patterns of Eligibility and Use of Novel Lipid‐Lowering Therapies in the United States

    Article • Journal of the American Heart Association, September 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  348. Use of lipid‐lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2‐year results from Getting to an imprOved Understanding of Low‐Density lipoprotein cholesterol and d...

    Article • Clinical Cardiology, September 2022, Wiley

    Professor Deepak L Bhatt

  349. Polypill Strategy in Secondary Cardiovascular Prevention

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2022, New England Journal of Medicine (NEJM/MMS)

    Prof HECTOR BUENO, MD, PhD ANTONIO PORTOLES, Prof. Francisco Marin , Prof. Vicente Andrés, Professor Deepak L Bhatt

  350. Corrigendum to: Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week

    Article • European Heart Journal, September 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  351. Association Between Periodontal Disease and Cardiovascular Disease (from the NHANES)

    Article • The American Journal of Cardiology, September 2022, Elsevier

    Professor Deepak L Bhatt

  352. Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients With Type 2 Diabetes

    Article • JAMA Cardiology, September 2022, American Medical Association (AMA)

    Professor Deepak L Bhatt

  353. Machine learning based model for risk prediction after ST-Elevation myocardial infarction: Insights from the North India ST elevation myocardial infarction (NORIN-STEMI) registry

    Article • International Journal of Cardiology, September 2022, Elsevier

    Professor Deepak L Bhatt

  354. (Optimizing Foundational Therapies in Patients With HFrEF. How Do We Translate These Findings Into Clinical Care? Translation of the document prepared by the Czech Society of Cardiology)

    Article • Cor et Vasa, September 2022, Czech Society of Cardiology

    Professor Deepak L Bhatt

  355. Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline

    Article • American Journal of Preventive Cardiology, September 2022, Elsevier

    Professor Deepak L Bhatt

  356. Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes

    Article • Journal of Clinical Lipidology, September 2022, Elsevier

    Professor Deepak L Bhatt

  357. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

    Article • Circulation, August 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  358. Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study

    Article • Journal of Thrombosis and Thrombolysis, August 2022, Springer Science + Business Media

    Professor Deepak L Bhatt

  359. The Relationship between Rate and Volume of Intravenous Fluid Administration and Kidney Outcomes after Angiography

    Article • Clinical Journal of the American Society of Nephrology, August 2022, American Society of Nephrology

    Professor Deepak L Bhatt

  360. The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, August 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  361. Cardiac Arrhythmias and Conduction Abnormalities in Patients with Type 2 Diabetes

    Article • August 2022, Research Square

    Professor Deepak L Bhatt

  362. Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial

    Article • Diabetes Care, August 2022, American Diabetes Association

    Professor Deepak L Bhatt

  363. Trends in Lipid Concentrations and Lipid Control Among US Adults, 2007-2018

    Article • JAMA, August 2022, American Medical Association (AMA)

    Professor Deepak L Bhatt

  364. Comparison of 6-Month Outcomes of Endovascular vs Surgical Revascularization for Patients With Critical Limb Ischemia

    Article • JAMA Network Open, August 2022, American Medical Association (AMA)

    Professor Deepak L Bhatt

  365. Range of Risk Factor Levels, Risk Control, and Temporal Trends for Nephropathy and End-stage Kidney Disease in Patients With Type 1 and Type 2 Diabetes

    Article • Diabetes Care, August 2022, American Diabetes Association

    Professor Deepak L Bhatt

  366. A polygenic risk score predicts atrial fibrillation in cardiovascular disease

    Article • European Heart Journal, August 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  367. Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?

    Article • European Heart Journal, August 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  368. Erratum to: Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease

    Article • European Heart Journal, August 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  369. Generalizability of the SURPASS‐2 Trial and Effect of Tirzepatide on US Diabetes and Obesity Control

    Article • Journal of the American Heart Association, August 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  370. Missed Opportunities for Screening and Management of Dysglycemia among Patients Presenting with Acute Myocardial Infarction in North India: The Prospective NORIN STEMI Registry

    Article • Global Heart, August 2022, Ubiquity Press, Ltd.

    Professor Deepak L Bhatt

  371. Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smoking

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, August 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  372. Effectiveness and safety of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a nationwide registry-based study

    Article • European Heart Journal Acute Cardiovascular Care, August 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  373. Prevalence and prognostic implications of reduced left ventricular ejection fraction among patients with STEMI in India

    Article • ESC Heart Failure, August 2022, Wiley

    Professor Deepak L Bhatt

  374. Prognostic significance of obstructive coronary artery disease in patients admitted with acute decompensated heart failure: the ARIC study community surveillance

    Article • European Journal of Heart Failure, August 2022, Wiley

    Professor Deepak L Bhatt

  375. Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week

    Article • European Heart Journal, August 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  376. Re‐examining the widespread policy of stopping sodium‐glucose cotransporter‐2 inhibitors during acute illness: A perspective based on the updated evidence

    Article • Diabetes Obesity and Metabolism, August 2022, Wiley

    Professor Deepak L Bhatt

  377. Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase...

    Article • Circulation, August 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  378. Left-Sided Degenerative Valvular Heart Disease in Type 1 and Type 2 Diabetes

    Article • Circulation, August 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  379. Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis

    Article • Circulation Cardiovascular Interventions, August 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  380. Left-sided Valvular Heart Disease and Survival in Out-of-Hospital Cardiac Arrest: A Nationwide Registry-Based Study

    Article • August 2022, Research Square

    Professor Deepak L Bhatt

  381. Prevalence and Prognostic Significance of Polyvascular Disease in Patients Hospitalized With Acute Decompensated Heart Failure: The ARIC Study

    Article • Journal of Cardiac Failure, August 2022, Elsevier

    Professor Deepak L Bhatt

  382. Procedure room innovation during the COVID-19 crisis: Protecting healthcare workers while learning from history

    Article • iScience, August 2022, Elsevier

    Professor Deepak L Bhatt

  383. Short- and Long-Term Clinical Outcomes Following Permanent Pacemaker Insertion Post-TAVR

    Article • JACC Cardiovascular Interventions, August 2022, Elsevier

    Professor Deepak L Bhatt

  384. Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke

    Article • JAMA Network Open, July 2022, American Medical Association (AMA)

    Professor Deepak L Bhatt

  385. Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry

    Article • Clinical Research in Cardiology, July 2022, Springer Science + Business Media

    Professor Deepak L Bhatt

  386. A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomes

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, July 2022, Elsevier

    Professor Deepak L Bhatt

  387. A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trial

    Article • EuroIntervention, July 2022, Europa Digital & Publishing

    Professor Deepak L Bhatt

  388. Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: Data from THEMIS and THEMIS PCI

    Article • American Heart Journal, July 2022, Elsevier

    Professor Deepak L Bhatt

  389. Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT

    Article • Journal of Clinical Lipidology, July 2022, Elsevier

    Professor Deepak L Bhatt

  390. Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial

    Article • The American Journal of Medicine, July 2022, Elsevier

    Professor Deepak L Bhatt

  391. Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants

    Article • JAMA Cardiology, July 2022, American Medical Association (AMA)

    Professor Deepak L Bhatt

  392. Geriatric and Palliative Care Specialists as Valued Members of the Multidisciplinary Heart Team

    Article • The American Journal of Medicine, July 2022, Elsevier

    Professor Deepak L Bhatt

  393. Meta-Analysis Assessing the Cardiovascular Safety of Semaglutide for the Treatment of Overweight or Obesity

    Article • The American Journal of Cardiology, July 2022, Elsevier

    Professor Deepak L Bhatt

  394. Meta-Analysis of Early Versus Delayed or Selective Coronary Angiography in Patients With Out-of-Hospital Cardiac Arrest Without ST-Elevation Myocardial Infarction

    Article • The American Journal of Cardiology, July 2022, Elsevier

    Professor Deepak L Bhatt

  395. Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention

    Article • Atherosclerosis, July 2022, Elsevier

    Professor Deepak L Bhatt

  396. Response by Cavender et al to Letter Regarding Article, “Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX”

    Article • Circulation Cardiovascular Interventions, July 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  397. Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial

    Article • European Heart Journal, June 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  398. Costs of Endoscopic vs Open Vein Harvesting for Coronary Artery Bypass Grafting

    Article • JAMA Network Open, June 2022, American Medical Association (AMA)

    Professor Deepak L Bhatt

  399. Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis

    Article • Circulation, June 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  400. Cardiovascular meta-analyses: fool’s gold or gold for fools?

    Article • European Heart Journal, June 2022, Oxford University Press (OUP)

    Prof. Giuseppe Biondi-Zoccai, Professor Deepak L Bhatt

  401. Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease

    Article • European Heart Journal, June 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  402. Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab

    Article • European Journal of Preventive Cardiology, June 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  403. P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention

    Article • Nature Reviews Cardiology, June 2022, Springer Science + Business Media

    Professor Deepak L Bhatt

  404. Cangrelor Use Patterns and Transition to Oral P2Y 12 Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry

    Article • Journal of the American Heart Association, June 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  405. Same‐Day Discharge After Transcatheter Aortic Valve Implantation: Insights from the Nationwide Readmission Database 2015 to 2019

    Article • Journal of the American Heart Association, June 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  406. Trend of Demographics of Cardiovascular Disease Fellows and Association Between Fellows and Program Director Race

    Article • JACC Advances, June 2022, Elsevier

    MD Monil Majmundar, Professor Deepak L Bhatt

  407. 481-P: Eligibility for Icosapent Ethyl in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: An Analysis of VERTIS CV

    Article • Diabetes, June 2022, American Diabetes Association

    James Mancuso, Professor Deepak L Bhatt

  408. POS0520 ASSOCIATION BETWEEN BASELINE STATIN TREATMENT AND MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF ORAL SURVEILLANCE

    Article • Annals of the Rheumatic Diseases, June 2022, Elsevier

    Professor Deepak L Bhatt

  409. Acute Decompensated Heart Failure in the Setting of Acute Coronary Syndrome

    Article • JACC Heart Failure, June 2022, Elsevier

    Professor Deepak L Bhatt

  410. Causes, Angiographic Characteristics, and Management of Premature Myocardial Infarction

    Article • Journal of the American College of Cardiology, June 2022, Elsevier

    Professor Deepak L Bhatt

  411. Design and rationale for the supermarket and web-based intervention targeting nutrition (SuperWIN) for cardiovascular risk reduction trial

    Article • American Heart Journal, June 2022, Elsevier

    Professor Deepak L Bhatt

  412. Evaluating the evaluators - Developing evidence of quality oversight effectiveness for clinical trial monitoring: Source data verification, source data review, statistical monitoring, key risk indicators, and direct measure of high risk errors

    Article • Contemporary Clinical Trials, June 2022, Elsevier

    Professor Deepak L Bhatt

  413. Forecasting Heart Failure Risk in Diabetes

    Article • Journal of the American College of Cardiology, June 2022, Elsevier

    Professor Deepak L Bhatt

  414. 864-P: Glycemic Control across eGFR Categories with the Dual SGLT1 and 2 Inhibitor Sotagliflozin in SCORED

    Article • Diabetes, June 2022, American Diabetes Association

    Professor Deepak L Bhatt

  415. OP0264 IMPACT OF BASELINE CARDIOVASCULAR RISK ON THE INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN THE TOFACITINIB RHEUMATOID ARTHRITIS CLINICAL PROGRAMME

    Article • Annals of the Rheumatic Diseases, June 2022, Elsevier

    Professor Deepak L Bhatt

  416. POS0110 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS STRATIFIED BY GEOGRAPHIC REGION AND BASELINE CARDIOVASCULAR RISK: A POST HOC ANALYSIS OF ORAL SURVEILLANCE

    Article • Annals of the Rheumatic Diseases, June 2022, Elsevier

    Professor Deepak L Bhatt

  417. POS0237 MAJOR ADVERSE CARDIOVASCULAR EVENTS, MALIGNANCIES AND VENOUS THROMBOEMBOLISM BY BASELINE CARDIOVASCULAR RISK: A POST HOC ANALYSIS OF ORAL SURVEILLANCE

    Article • Annals of the Rheumatic Diseases, June 2022, Elsevier

    Professor Deepak L Bhatt

  418. No Diagnostic Concerns With Cardiovascular Magnetic Resonance Imaging in Patients With Breast Cancer and Breast Implants—Reply

    Article • JAMA Cardiology, June 2022, American Medical Association (AMA)

    Professor Deepak L Bhatt

  419. POS0519 RELATIONSHIP BETWEEN DISEASE ACTIVITY AND MAJOR ADVERSE EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON TOFACITINIB OR TNF INHIBITORS: A POST HOC ANALYSIS OF ORAL SURVEILLANCE

    Article • Annals of the Rheumatic Diseases, June 2022, Elsevier

    Professor Deepak L Bhatt

  420. POS0674 RISK FACTORS FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS AGED ≥50 YEARS WITH RHEUMATOID ARTHRITIS AND ≥1 ADDITIONAL CARDIOVASCULAR RISK FACTOR: A POST HOC ANALYSIS OF ORAL SURVEILLANCE

    Article • Annals of the Rheumatic Diseases, June 2022, Elsevier

    Professor Deepak L Bhatt

  421. Secular Trends in Prevalence of Heart Failure Diagnosis over 20 Years (from the US NHANES)

    Article • The American Journal of Cardiology, June 2022, Elsevier

    Professor Deepak L Bhatt

  422. The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl

    Article • American Journal of Preventive Cardiology, June 2022, Elsevier

    Professor Deepak L Bhatt

  423. The collateral damage of COVID-19 to cardiovascular services: a meta-analysis

    Article • European Heart Journal, May 2022, Oxford University Press (OUP)

    Prof. Giuseppe Biondi-Zoccai, Professor Deepak L Bhatt

  424. Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial

    Article • Circulation, May 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  425. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 2022, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt

  426. Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial

    Article • Catheterization and Cardiovascular Interventions, May 2022, Wiley

    Professor Deepak L Bhatt

  427. Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke

    Article • JAMA Internal Medicine, May 2022, American Medical Association (AMA)

    Professor Deepak L Bhatt

  428. Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial

    Article • The Lancet Diabetes & Endocrinology, May 2022, Elsevier

    Professor Deepak L Bhatt

  429. Optimizing Foundational Therapies in Patients With HFrEF

    Article • JACC Basic to Translational Science, May 2022, Elsevier

    Professor Deepak L Bhatt

  430. Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction

    Article • Journal of the American College of Cardiology, May 2022, Elsevier

    Professor Deepak L Bhatt

  431. Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin Following WATCHMAN in High-Risk Patients

    Article • Journal of the Society for Cardiovascular Angiography & Interventions, May 2022, Elsevier

    Professor Deepak L Bhatt

  432. Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction

    Article • Journal of the American College of Cardiology, May 2022, Elsevier

    Professor Deepak L Bhatt

  433. The National Cardiovascular Data Registry Data Quality Program 2020

    Article • Journal of the American College of Cardiology, May 2022, Elsevier

    Professor Deepak L Bhatt

  434. Cost–effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, April 2022, Oxford University Press (OUP)

    Prof HECTOR BUENO, Professor Deepak L Bhatt

  435. Association of Influenza Vaccination With Cardiovascular Risk

    Article • JAMA Network Open, April 2022, American Medical Association (AMA)

    Professor Deepak L Bhatt

  436. Supermarket and Web-based Intervention Targeting Nutrition (SuperWIN): A Randomized, Parallel Assignment, Active Control, Efficacy Trial

    Article • April 2022, Springer Science + Business Media

    Professor Deepak L Bhatt

  437. Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCI

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, April 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  438. Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, April 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  439. Generalizability of FIGARO‐DKD and FIDELIO‐DKD Trial Criteria to the US Population Eligible for Finerenone

    Article • Journal of the American Heart Association, April 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  440. Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE‐IT

    Article • Journal of the American Heart Association, April 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  441. Achieving More Rapid Door-to-Needle Times and Improved Outcomes in Acute Ischemic Stroke in a Nationwide Quality Improvement Intervention

    Article • Stroke, April 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  442. Socioeconomic disparities in healthcare utilization for atherosclerotic cardiovascular disease

    Article • American Heart Journal, April 2022, Elsevier

    Professor Deepak L Bhatt

  443. Association Between Endovascular Therapy Time to Treatment and Outcomes in Patients With Basilar Artery Occlusion

    Article • Circulation, March 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  444. Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE‐IT PCI

    Article • Journal of the American Heart Association, March 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  445. Circulating linoleic acid at the time of myocardial infarction and risk of primary ventricular fibrillation

    Article • Scientific Reports, March 2022, Springer Science + Business Media

    Professor Deepak L Bhatt

  446. Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention

    Article • Current Cardiology Reports, March 2022, Springer Science + Business Media

    Professor Deepak L Bhatt

  447. Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association

    Article • Circulation, March 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  448. Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION

    Article • Circulation Cardiovascular Interventions, March 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  449. Guideline based eligibility for primary prevention statin therapy – Insights from the North India ST-elevation myocardial infarction registry (NORIN-STEMI)

    Article • Journal of Clinical Lipidology, March 2022, Elsevier

    Professor Deepak L Bhatt

  450. Out-of-Pocket Costs for SGLT-2 (Sodium-Glucose Transport Protein-2) Inhibitors in the United States

    Article • Circulation Heart Failure, March 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  451. P2Y12 inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials

    Article • European Heart Journal Open, March 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  452. Potential Impact of the 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease Recommendations on the Inappropriate Routine Use of Aspirin and Aspirin Use Without a Recommended Indication for Primary Prevention of Cardiovascular Di...

    Article • Circulation Cardiovascular Quality and Outcomes, March 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  453. Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Severe Hypertriglyceridemia (SHTG) – Initial Baseline data from an Ongoing Phase 2 Study

    Article • Metabolism, March 2022, Elsevier

    Professor Deepak L Bhatt

  454. Trends in 30-Day and 90-Day Readmission Rates After Transcatheter Aortic Valve Implantation

    Article • The American Journal of Cardiology, March 2022, Elsevier

    Professor Deepak L Bhatt

  455. Virtual and Augmented Reality in Cardiovascular Care

    Article • JACC Cardiovascular Imaging, March 2022, Elsevier

    Professor Deepak L Bhatt

  456. Association of Recent Use of Non–Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase

    Article • JAMA, February 2022, American Medical Association (AMA)

    Professor Deepak L Bhatt

  457. Seasonal Variation of Atrial Fibrillation Admission and Quality of Care in the United States

    Article • Journal of the American Heart Association, February 2022, Wolters Kluwer Health

    Dr. Roland A. Matsouaka, Professor Deepak L Bhatt

  458. Diagnosis and Treatment of Acute Coronary Syndromes

    Article • JAMA, February 2022, American Medical Association (AMA)

    Professor Deepak L Bhatt

  459. Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

    Article • European Heart Journal, February 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  460. Corrigendum to: Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, February 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  461. Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment

    Article • JAMA Network Open, February 2022, American Medical Association (AMA)

    Professor Deepak L Bhatt

  462. Addressing Imaging Pitfalls to Reduce Cardiovascular Disease Misdiagnosis in Patients With Breast Cancer Following Reconstruction

    Article • JAMA Cardiology, February 2022, American Medical Association (AMA)

    Professor Deepak L Bhatt

  463. DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases

    Article • Journal of Diabetes and its Complications, February 2022, Elsevier

    Professor Deepak L Bhatt

  464. Fire or Ice

    Article • JACC Basic to Translational Science, February 2022, Elsevier

    Professor Deepak L Bhatt

  465. Is the affordable care act medicaid expansion associated with receipt of heart failure guideline-directed medical therapy by race and ethnicity?

    Article • American Heart Journal, February 2022, Elsevier

    Professor Deepak L Bhatt

  466. Prognostic implications of serial high-sensitivity cardiac troponin testing among patients with COVID-19: A Danish nationwide registry-based cohort study

    Article • American Heart Journal Plus Cardiology Research and Practice, February 2022, Elsevier

    Professor Deepak L Bhatt

  467. The early reduction of left ventricular mass after sleeve gastrectomy depends on the fall of branched-chain amino acid circulating levels

    Article • EBioMedicine, February 2022, Elsevier

    Professor Deepak L Bhatt

  468. In NSTEMI, are patients without SMuRFs real?

    Article • European Journal of Preventive Cardiology, January 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  469. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 2022, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt

  470. Methodological Standards for the Design, Implementation, and Analysis of Randomized Trials in Cardiac Surgery: A Scientific Statement From the American Heart Association

    Article • Circulation, January 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  471. Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation

    Article • Clinical Pharmacokinetics, January 2022, Springer Science + Business Media

    Professor Deepak L Bhatt

  472. Effect of Dapagliflozin on Hematocrit in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From DECLARE-TIMI 58

    Article • Diabetes Care, January 2022, American Diabetes Association

    Professor Deepak L Bhatt

  473. Early and late recurrent cardiovascular events among high‐risk patients with an acute coronary syndrome: Meta‐analysis of phase III studies and implications on trial design

    Article • Clinical Cardiology, January 2022, Wiley

    Gerald Chi, Professor Deepak L Bhatt

  474. Association of Baseline HbA1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58

    Article • Diabetes Care, January 2022, American Diabetes Association

    Professor Deepak L Bhatt

  475. Impact of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials

    Article • Journal of Cardiovascular Development and Disease, January 2022, MDPI AG

    Professor Deepak L Bhatt

  476. Response to the Letter on “The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus”

    Article • Cardiovascular Drugs and Therapy, January 2022, Springer Science + Business Media

    Professor Deepak L Bhatt

  477. Relationship Between Myocardial Injury During Index Hospitalization for SARS‐CoV‐2 Infection and Longer‐Term Outcomes

    Article • Journal of the American Heart Association, January 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  478. The year in cardiovascular medicine 2021: diabetes and metabolic disorders

    Article • European Heart Journal, January 2022, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  479. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain

    Article • Journal of Cardiovascular Computed Tomography, January 2022, Elsevier

    Professor Deepak L Bhatt

  480. Consistency of Benefit of Icosapent Ethyl by Background Statin Type in REDUCE-IT

    Article • Journal of the American College of Cardiology, January 2022, Elsevier

    Professor Deepak L Bhatt

  481. Has Unstable Angina Become a Vestigial of the Past in Clinical Trial Primary Endpoints?

    Article • Cardiology, January 2022, Karger Publishers

    Professor Deepak L Bhatt

  482. In-Stent Restenosis in Saphenous Vein Grafts (from the DIVA Trial)

    Article • The American Journal of Cardiology, January 2022, Elsevier

    Professor Deepak L Bhatt

  483. Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX

    Article • Circulation Cardiovascular Interventions, January 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  484. Rationale and pathways forward in the implementation of coronary artery calcium-based enrichment of randomized trials

    Article • American Heart Journal, January 2022, Elsevier

    Professor Deepak L Bhatt

  485. Substantial Impact of Eicosapentaenoic Acid on Cardiovascular Outcomes in the REDUCE-IT Trial

    Article • CardioMetabolic Syndrome Journal, January 2022, XMLink

    Professor Deepak L Bhatt

  486. Ten-Year Trends in Patient Characteristics, Treatments, and Outcomes in Myocardial Infarction From National Cardiovascular Data Registry Chest Pain–MI Registry

    Article • Circulation Cardiovascular Quality and Outcomes, January 2022, Wolters Kluwer Health

    Professor Deepak L Bhatt

  487. The 2021 Chest Pain Guideline

    Article • JACC Cardiovascular Imaging, January 2022, Elsevier

    Professor Deepak L Bhatt

  488. Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19

    Article • JAMA Network Open, December 2021, American Medical Association (AMA)

    Professor Deepak L Bhatt

  489. Correction to: The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus

    Article • Cardiovascular Drugs and Therapy, December 2021, Springer Science + Business Media

    Professor Deepak L Bhatt

  490. Cardiovascular Safety Assessment in Cancer Drug Development

    Article • Journal of the American Heart Association, December 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  491. Passive longitudinal weight and cardiopulmonary monitoring in the home bed

    Article • Scientific Reports, December 2021, Springer Science + Business Media

    Professor Deepak L Bhatt

  492. Alirocumab after acute coronary syndrome in patients with a history of heart failure

    Article • European Heart Journal, December 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  493. Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis

    Article • Frontiers in Cardiovascular Medicine, December 2021, Frontiers

    Gerald Chi, Professor Deepak L Bhatt

  494. Intensive blood pressure control in patients with a history of heart failure: the Systolic Blood Pressure Intervention Trial (SPRINT)

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, December 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  495. Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG

    Article • Circulation, December 2021, Wolters Kluwer Health

    Dr Dimitar Sajkov, Professor Deepak L Bhatt

  496. Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic Stroke With Aspirin Treatment Failure

    Article • Stroke, December 2021, Wolters Kluwer Health

    Dr. Roland A. Matsouaka, Professor Deepak L Bhatt

  497. Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis

    Article • JACC CardioOncology, December 2021, Elsevier

    Professor Deepak L Bhatt

  498. Incidence of Myocardial Infarction Types in Patients Treated With Ticagrelor in the THEMIS Trial

    Article • Circulation Cardiovascular Interventions, December 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  499. Race and Ethnicity Considerations in Patients With Coronary Artery Disease and Stroke

    Article • Journal of the American College of Cardiology, December 2021, Elsevier

    Professor Deepak L Bhatt

  500. Renal Denervation for Hypertension

    Article • JACC Cardiovascular Interventions, December 2021, Elsevier

    Professor Deepak L Bhatt

  501. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

    Article • Circulation, November 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  502. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

    Article • Circulation, November 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  503. Correction to: 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

    Article • Circulation, November 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  504. Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL

    Article • Circulation, November 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  505. Vascular repair and regeneration in cardiometabolic diseases

    Article • European Heart Journal, November 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  506. Left circumflex artery injury following surgical mitral valve replacement: a case report

    Article • European Heart Journal - Case Reports, November 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  507. Assessing reproducibility and utility of clustering of patients with type 2 diabetes and established CV disease (SAVOR -TIMI 53 trial)

    Article • PLOS One, November 2021, PLOS

    Professor Deepak L Bhatt

  508. Recruitment Practices in Multicenter Randomized Clinical Trials: Time for a Relook

    Article • Journal of the American Heart Association, November 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  509. Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta‐analysis

    Article • Catheterization and Cardiovascular Interventions, November 2021, Wiley

    Professor Jolanta M Siller-Matula, Professor Deepak L Bhatt

  510. Population pharmacokinetic–pharmacodynamic modeling of PB2452, a monoclonal antibody fragment being developed as a ticagrelor reversal agent, in healthy volunteers

    Article • CPT Pharmacometrics & Systems Pharmacology, November 2021, Wiley

    Professor Deepak L Bhatt

  511. The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus

    Article • Cardiovascular Drugs and Therapy, November 2021, Springer Science + Business Media

    Professor Deepak L Bhatt

  512. The reduction in cardiovascular risk in REDUCE-IT is due to eicosapentaenoic acid in icosapent ethyl

    Article • European Heart Journal, November 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  513. Publisher Correction: Cardiac involvement in the long-term implications of COVID-19

    Article • Nature Reviews Cardiology, November 2021, Springer Science + Business Media

    Professor Deepak L Bhatt

  514. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive Summary

    Article • Journal of the American College of Cardiology, November 2021, Elsevier

    Professor Deepak L Bhatt

  515. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain

    Article • Journal of the American College of Cardiology, November 2021, Elsevier

    Professor Deepak L Bhatt

  516. Development and external validation of a prognostic model for ischaemic stroke after surgery

    Article • British Journal of Anaesthesia, November 2021, Elsevier

    Professor Deepak L Bhatt

  517. Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI

    Article • Journal of the American College of Cardiology, November 2021, Elsevier

    Professor Deepak L Bhatt

  518. EMPEROR-Preserved: A promise fulfilled

    Article • Cell Metabolism, November 2021, Elsevier

    Professor Deepak L Bhatt

  519. Improving Communication of Incidental Imaging Findings

    Article • Mayo Clinic Proceedings, November 2021, Elsevier

    Professor Deepak L Bhatt

  520. Innovation in intervention

    Article • Progress in Cardiovascular Diseases, November 2021, Elsevier

    Professor Deepak L Bhatt

  521. Outcomes of Endovascular Therapy in Patients With Prestroke Mobility Impairment

    Article • Stroke, November 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  522. SGLT-2 inhibitors in heart failure: Time for broader eligibility and earlier initiation

    Article • Cleveland Clinic Journal of Medicine, November 2021, Cleveland Clinic Journal of Medicine

    Professor Deepak L Bhatt

  523. Serum Potassium and Mortality in High-Risk Patients: SPRINT

    Article • Hypertension, November 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  524. The role of eicosapentaenoic acid in reducing important cardiovascular events, including coronary revascularization

    Article • Progress in Cardiovascular Diseases, November 2021, Elsevier

    Professor Deepak L Bhatt

  525. A tail of two diagnoses: Supporting patients with both COPD and Cardiovascular risks

    Article • October 2021, Springer Science + Business Media

    Professor Kenneth R Chapman, Professor Deepak L Bhatt

  526. Cardiac involvement in the long-term implications of COVID-19

    Article • Nature Reviews Cardiology, October 2021, Springer Science + Business Media

    Professor Deepak L Bhatt

  527. Women and Diabetes: Preventing Heart Disease in a New Era of Therapies

    Article • European Cardiology Review, October 2021, Medical Media Communications, Ltd. T/A Radcliffe Cardiology

    Professor Deepak L Bhatt

  528. Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial

    Article • Circulation, October 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  529. Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, October 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  530. Time to Remove the Left Atrial Appendage at Surgery: LAAOS III in Perspective

    Article • Circulation, October 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  531. Meta-Analysis of Transradial Versus Transfemoral Access for Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease

    Article • The American Journal of Cardiology, October 2021, Elsevier

    Professor Jolanta M Siller-Matula, Professor Deepak L Bhatt

  532. Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination

    Article • The American Journal of Cardiology, October 2021, Elsevier

    Professor Deepak L Bhatt

  533. Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention

    Article • Journal of the American College of Cardiology, October 2021, Elsevier

    Professor Deepak L Bhatt

  534. Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT

    Article • Journal of the American College of Cardiology, October 2021, Elsevier

    Professor Deepak L Bhatt

  535. Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) regi...

    Article • International Journal of Cardiology, October 2021, Elsevier

    Professor Deepak L Bhatt

  536. Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19

    Article • Journal of the American College of Cardiology, October 2021, Elsevier

    Professor Deepak L Bhatt

  537. Omega-3 and omega-6 fatty acids have distinct effects on endothelial fatty acid content and nitric oxide bioavailability

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, October 2021, Elsevier

    Professor Deepak L Bhatt

  538. Same-day discharge after transcatheter mitral valve repair using MitraClip in a tertiary community hospital: a case series

    Article • European Heart Journal - Case Reports, October 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  539. A novel technique for invasive aortic valve pressure gradient measurement using a 6 Fr Swan-Ganz catheter: a case series

    Article • European Heart Journal - Case Reports, September 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  540. A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes

    Article • Diabetes Care, September 2021, American Diabetes Association

    Professor Deepak L Bhatt

  541. A structured review of the ASCENT Study for COPD

    Article • Advances in Therapy, September 2021, Springer Science + Business Media

    Professor Kenneth R Chapman, Professor Deepak L Bhatt

  542. The Impact of American College of Cardiology Chest Pain Center Accreditation on Guideline Recommended Acute Myocardial Infarction Management

    Article • Critical Pathways in Cardiology A Journal of Evidence-Based Medicine, September 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  543. Icosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglycerides

    Article • Expert Opinion on Drug Safety, September 2021, Taylor & Francis

    Professor Deepak L Bhatt

  544. Long‐Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS‐TIMI 54 Trial

    Article • Journal of the American Heart Association, September 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  545. 2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure

    Article • Journal of Thoracic and Cardiovascular Surgery, September 2021, Elsevier

    Professor Deepak L Bhatt

  546. 3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation

    Article • JACC Cardiovascular Interventions, September 2021, Elsevier

    Professor Deepak L Bhatt

  547. A randomized trial of icosapent ethyl in ambulatory patients with COVID-19

    Article • iScience, September 2021, Elsevier

    Professor Deepak L Bhatt

  548. Adaptive Trials in Cardiology: Some Considerations and Examples

    Article • Canadian Journal of Cardiology, September 2021, Elsevier

    Professor Deepak L Bhatt

  549. Coronary artery bypass grafting surgery versus percutaneous coronary intervention for coronary artery disease

    Article • Cochrane Database of Systematic Reviews, September 2021, Wiley

    Professor Deepak L Bhatt

  550. Efficacy and safety of cangrelor in patients with peripheral artery disease undergoing percutaneous coronary intervention – Insights from the CHAMPION program

    Article • American Heart Journal Plus Cardiology Research and Practice, September 2021, Elsevier

    Professor Deepak L Bhatt

  551. Intracranial Hemorrhage During Dual Antiplatelet Therapy

    Article • Journal of the American College of Cardiology, September 2021, Elsevier

    Professor Deepak L Bhatt

  552. Meta-Analysis of Contemporary Trials of Omega-3 Fatty Acids Containing Both Eicosapentaenoic and Docosahexaenoic Acids

    Article • EClinicalMedicine, September 2021, Elsevier

    Professor Deepak L Bhatt

  553. Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United States

    Article • Progress in Cardiovascular Diseases, September 2021, Elsevier

    Professor Deepak L Bhatt

  554. Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US

    Article • JAMA Cardiology, September 2021, American Medical Association (AMA)

    Professor Deepak L Bhatt

  555. Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies

    Article • Circulation, August 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  556. Effect of Continuous Electrocardiogram Monitoring on Detection of Undiagnosed Atrial Fibrillation After Hospitalization for Cardiac Surgery

    Article • JAMA Network Open, August 2021, American Medical Association (AMA)

    Professor Deepak L Bhatt

  557. Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE–TIMI 58 trial

    Article • European Heart Journal, August 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  558. Bleeding avoidance strategies in percutaneous coronary intervention

    Article • Nature Reviews Cardiology, August 2021, Springer Science + Business Media

    Professor Deepak L Bhatt

  559. Reporting of Race and Ethnicity in Medical and Scientific Journals

    Article • JAMA, August 2021, American Medical Association (AMA)

    Professor Deepak L Bhatt

  560. What Do US Physicians and Patients Think About Lipid‐Lowering Therapy and Goals of Treatment? Results From the GOULD Registry

    Article • Journal of the American Heart Association, August 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  561. Cardiovascular effects of non-insulin glucose-lowering agents: a comprehensive review of trial evidence and potential cardioprotective mechanisms

    Article • Cardiovascular Research, August 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  562. Patient-specific computational simulation of coronary artery bifurcation stenting

    Article • Scientific Reports, August 2021, Springer Science + Business Media

    Professor Deepak L Bhatt

  563. Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI

    Article • Journal of Thrombosis and Thrombolysis, August 2021, Springer Science + Business Media

    Professor Deepak L Bhatt

  564. Natural language processing for the assessment of cardiovascular disease comorbidities: The cardio‐Canary comorbidity project

    Article • Clinical Cardiology, August 2021, Wiley

    Professor Deepak L Bhatt

  565. Association of Socioeconomic Disadvantage With Long-term Mortality After Myocardial Infarction

    Article • JAMA Cardiology, August 2021, American Medical Association (AMA)

    Professor Deepak L Bhatt

  566. Comparative Outcomes of Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction Among Medicare Beneficiaries With Multivessel Coronary Artery Disease: An National Cardiovascular Data Registry Research to Practice Project

    Article • Circulation Cardiovascular Interventions, August 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  567. Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial

    Article • EuroIntervention, August 2021, Europa Digital & Publishing

    Professor Deepak L Bhatt

  568. Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis

    Article • EClinicalMedicine, August 2021, Elsevier

    Professor Deepak L Bhatt

  569. Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure

    Article • Annals of Internal Medicine, August 2021, American College of Physicians

    Professor Deepak L Bhatt

  570. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Article • Journal of the American College of Cardiology, August 2021, Elsevier

    Professor Deepak L Bhatt

  571. Nationally Representative Repeat Transcatheter Aortic Valve Replacement Outcomes

    Article • JACC Cardiovascular Interventions, August 2021, Elsevier

    Professor Deepak L Bhatt

  572. New Antidiabetes Medications and Their Cardiovascular and Renal Benefits

    Article • Cardiology Clinics, August 2021, Elsevier

    Professor Deepak L Bhatt

  573. Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention

    Article • International Journal of Cardiology, August 2021, Elsevier

    Professor Deepak L Bhatt

  574. Role of Cardiac CT in Pre-Procedure Planning for Transcatheter Mitral Valve Replacement

    Article • JACC Cardiovascular Imaging, August 2021, Elsevier

    Professor Deepak L Bhatt

  575. Same-Day Discharge After Elective PCI

    Article • JACC Cardiovascular Interventions, August 2021, Elsevier

    Professor Deepak L Bhatt

  576. Trends in Cerebral Embolic Protection Device Use and Association With Stroke Following Transcatheter Aortic Valve Implantation

    Article • The American Journal of Cardiology, August 2021, Elsevier

    Professor Deepak L Bhatt

  577. Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital Perspective

    Article • American Journal of Cardiovascular Drugs, July 2021, Springer Science + Business Media

    Professor Deepak L Bhatt

  578. Reconfiguring the Cardiovascular Clinical Trial Enterprise in the United States

    Article • JAMA Network Open, July 2021, American Medical Association (AMA)

    Professor Deepak L Bhatt

  579. The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58

    Article • Diabetes Care, July 2021, American Diabetes Association

    Ofri Mosenzon, Professor Deepak L Bhatt

  580. Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives

    Article • Journal of the American Heart Association, July 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  581. Does SGLT1 Inhibition Add Benefit to SGLT2 Inhibition in Type 2 Diabetes?

    Article • Circulation, July 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  582. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes

    Article • JAMA Cardiology, July 2021, American Medical Association (AMA)

    Professor Deepak L Bhatt

  583. Generalizability of DAPA-CKD to the United States

    Article • Circulation Cardiovascular Quality and Outcomes, July 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  584. Hospital Readmission in Patients With Spontaneous Coronary Artery Dissection

    Article • The American Journal of Cardiology, July 2021, Elsevier

    Professor Deepak L Bhatt

  585. Impact of Chronic Kidney Disease on Revascularization and Outcomes in Patients with ST-Elevation Myocardial Infarction

    Article • The American Journal of Cardiology, July 2021, Elsevier

    Professor Deepak L Bhatt

  586. Improving Terminology to Describe Coronary Artery Procedures

    Article • Journal of the American College of Cardiology, July 2021, Elsevier

    Professor Deepak L Bhatt

  587. Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease

    Article • Journal of the American College of Cardiology, July 2021, Elsevier

    Professor Deepak L Bhatt

  588. The Emerging Role of Coronary Computed Tomography Angiography in Stable Angina With ISCHEMIA

    Article • JACC Cardiovascular Imaging, July 2021, Elsevier

    Professor Deepak L Bhatt

  589. Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, June 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  590. Characteristics of Randomized Clinical Trials in Surgery From 2008 to 2020

    Article • JAMA Network Open, June 2021, American Medical Association (AMA)

    Professor Deepak L Bhatt

  591. Association between COVID-19 outcomes and mask mandates, adherence, and attitudes

    Article • PLOS One, June 2021, PLOS

    Professor Deepak L Bhatt

  592. Predictors of angina resolution after percutaneous coronary intervention in stable coronary artery disease

    Article • Coronary Artery Disease, June 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  593. Patient-reported Outcomes After Metabolic Surgery Versus Medical Therapy for Diabetes

    Article • Annals of Surgery, June 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  594. Accuracy of ICD-10 Diagnostic Codes to Identify COVID-19 Among Hospitalized Patients

    Article • Journal of General Internal Medicine, June 2021, Springer Science + Business Media

    Professor Deepak L Bhatt

  595. Mapping and quantification of the twitter footprint of cardiologists

    Article • European Heart Journal - Digital Health, June 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  596. 256-OR: Substantial Cardiovascular Risk Reduction with Icosapent Ethyl Regardless of Diabetes Status or BMI: REDUCE-IT BMI

    Article • Diabetes, June 2021, American Diabetes Association

    Professor Deepak L Bhatt

  597. 788-P: The Cardiovascular and Renal Benefits of Dapagliflozin Are Independent of Baseline HbA1c: Analyses from DECLARE-TIMI 58

    Article • Diabetes, June 2021, American Diabetes Association

    Professor Deepak L Bhatt

  598. Guía ESC 2020 sobre el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST

    Article • Revista Española de Cardiología, June 2021, Elsevier

    Professor Deepak L Bhatt

  599. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

    Article • Revista Española de Cardiología (English Edition), June 2021, Elsevier

    Professor Deepak L Bhatt

  600. Association Between Omega‐3 Fatty Acid Levels and Risk for Incident Major Bleeding Events and Atrial Fibrillation: MESA

    Article • Journal of the American Heart Association, June 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  601. Long-Term Outcomes Following Myocardial Infarction in Young Adult Survivors of Hodgkin Lymphoma

    Article • JACC CardioOncology, June 2021, Elsevier

    Professor Deepak L Bhatt

  602. SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysis

    Article • EClinicalMedicine, June 2021, Elsevier

    Professor Deepak L Bhatt

  603. The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE‐DUAL PCI subgroup analysis and comparison to othe...

    Article • Clinical Cardiology, May 2021, Wiley

    Professor Deepak L Bhatt

  604. Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease

    Article • Heart, May 2021, BMJ

    Professor Deepak L Bhatt

  605. Corrigendum to: 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent S...

    Article • European Heart Journal, May 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  606. Patient perspectives on the need for implanted device information: Implications for a post‐procedural communication framework

    Article • Health Expectations, May 2021, Wiley

    Professor Deepak L Bhatt

  607. Panomics: New Databases for Advancing Cardiology

    Article • Frontiers in Cardiovascular Medicine, May 2021, Frontiers

    Professor Deepak L Bhatt

  608. The EVAPORATE trial provides important mechanistic data on plaque characteristics that have relevance to the REDUCE-IT results and clinical use of icosapent ethyl

    Article • European Heart Journal, May 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  609. Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials

    Article • Journal of the American College of Cardiology, May 2021, Elsevier

    Prof HECTOR BUENO, Professor Deepak L Bhatt

  610. ASSOCIATION OF CHOLESTEROL EFFLUX CAPACITY WITH ADVERSE CARDIOVASCULAR OUTCOMES - A META-ANALYSIS

    Article • Journal of the American College of Cardiology, May 2021, Elsevier

    Gerald Chi, Professor Deepak L Bhatt

  611. EARLY AND LATE RECURRENT CARDIOVASCULAR RISK IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME - META-ANALYSIS AND IMPLICATIONS IN TRIAL DESIGN

    Article • Journal of the American College of Cardiology, May 2021, Elsevier

    Gerald Chi, Professor Deepak L Bhatt

  612. COMPREHENSIVE PHARMACOLOGIC THERAPIES FOR THE PREVENTION OF CARDIORENAL OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: A COMPARATIVE ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    Article • Journal of the American College of Cardiology, May 2021, Elsevier

    Professor Deepak L Bhatt

  613. Coronary Artery Calcium to Improve the Efficiency of Randomized Controlled Trials in Primary Cardiovascular Prevention

    Article • JACC Cardiovascular Imaging, May 2021, Elsevier

    Professor Deepak L Bhatt

  614. Device-Related Thrombus After Left Atrial Appendage Closure: Data on Thrombus Characteristics, Treatment Strategies, and Clinical Outcomes From the EUROC-DRT-Registry

    Article • Circulation Cardiovascular Interventions, May 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  615. ICOSAPENT ETHYL REDUCES ISCHEMIC EVENTS IN PATIENTS WITH HIGH TRIGLYCERIDES AND LOW HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS: REDUCE-IT HIGH TG/LOW HDL-C ANALYSES

    Article • Journal of the American College of Cardiology, May 2021, Elsevier

    Professor Deepak L Bhatt

  616. Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure

    Article • Journal of the American College of Cardiology, May 2021, Elsevier

    Professor Deepak L Bhatt

  617. Impella in Cardiogenic Shock: Is it Time to Hit the Break?

    Article • Shock, May 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  618. Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE)

    Article • American Heart Journal, May 2021, Elsevier

    Professor Deepak L Bhatt

  619. Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States

    Article • JAMA Cardiology, May 2021, American Medical Association (AMA)

    Professor Deepak L Bhatt

  620. Variation in treatment strategy for NSTEMI: A complex phenomenon

    Article • International Journal of Cardiology, May 2021, Elsevier

    Professor Deepak L Bhatt

  621. Cardiovascular Outcomes with Sotagliflozin

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2021, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt

  622. To stent or not to stent? Treating angina after ISCHEMIA—introduction

    Article • European Heart Journal, April 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  623. To stent or not to stent? Treating angina after ISCHEMIA—the impact of the ISCHEMIA trial on the indications for angiography and revascularization in patients with stable coronary artery disease

    Article • European Heart Journal, April 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  624. Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk

    Article • JAMA, April 2021, American Medical Association (AMA)

    Professor Deepak L Bhatt

  625. Causes and Risk Factors for Death in Diabetes

    Article • Journal of the American College of Cardiology, April 2021, Elsevier

    Professor Deepak L Bhatt

  626. Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial

    Article • JACC Cardiovascular Interventions, April 2021, Elsevier

    Professor Deepak L Bhatt

  627. Increased Prevalence of Myocardial Injury in Patients with SARS-CoV-2 Viremia

    Article • The American Journal of Medicine, April 2021, Elsevier

    Professor Deepak L Bhatt

  628. Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension

    Article • The American Journal of Medicine, April 2021, Elsevier

    Professor Deepak L Bhatt, Dr. Richard M Allman

  629. The Future of Aspirin Therapy in Cardiovascular Disease

    Article • The American Journal of Cardiology, April 2021, Elsevier

    Professor Deepak L Bhatt

  630. Transmitting Device Identifiers of Implants From the Point of Care to Insurers: A Demonstration Project

    Article • Journal of Patient Safety, April 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  631. Association of inflammatory disease and long-term outcomes among young adults with myocardial infarction: the Mass General Brigham YOUNG-MI Registry

    Article • European Journal of Preventive Cardiology, March 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  632. Corrigendum to: Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity score matching analysis

    Article • European Heart Journal Acute Cardiovascular Care, March 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  633. Letter by Angiolillo et al Regarding Article, “Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment–Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial”

    Article • Circulation, March 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  634. Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol

    Article • Circulation, March 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  635. Reoperative Mitral Surgery Versus Transcatheter Mitral Valve Replacement: A Systematic Review

    Article • Journal of the American Heart Association, March 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  636. Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

    Article • Diabetes Care, March 2021, American Diabetes Association

    Prof. Francisco Marin , Professor Deepak L Bhatt

  637. Intermediate-Term Outcomes of Endoscopic or Open Vein Harvesting for Coronary Artery Bypass Grafting

    Article • JAMA Network Open, March 2021, American Medical Association (AMA)

    Professor Deepak L Bhatt

  638. Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies

    Article • Journal of Thrombosis and Thrombolysis, March 2021, Springer Science + Business Media

    Professor Deepak L Bhatt

  639. The association between coronary graft patency and clinical status in patients with coronary artery disease

    Article • European Heart Journal, March 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  640. Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA

    Article • European Heart Journal, March 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  641. Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58

    Article • Diabetes Care, March 2021, American Diabetes Association

    Avivit Cahn, Professor Deepak L Bhatt

  642. Linear and Nonlinear Mendelian Randomization Analyses of the Association Between Diastolic Blood Pressure and Cardiovascular Events

    Article • Circulation, March 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  643. Cardiovascular disease and stroke risk assessment in patients with chronic kidney disease using integration of estimated glomerular filtration rate, ultrasonic image phenotypes, and artificial intelligence: a narrative review

    Article • International Angiology, March 2021, Edizioni Minerva Medica

    Professor Deepak L Bhatt

  644. Crossover in COAPT

    Article • Journal of the American College of Cardiology, March 2021, Elsevier

    Professor Deepak L Bhatt

  645. Abstract P252: Discharge Antithrombotic Therapy for Ischemic Stroke Patients With Prior Aspirin Failure

    Article • Stroke, March 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  646. Eicosapentaenoic Acid Enhances Protein Expression Linked to Nitric Oxide Synthase Activation and Bioavailability in Contrast to Docosahexaenoic and Arachidonic Acids

    Article • Metabolism, March 2021, Elsevier

    Professor Deepak L Bhatt

  647. Eicosapentaenoic Acid Reduced Expression of Inflammatory Proteins in Vascular Endothelial Cells during Cytokine Treatment in Vitro

    Article • Metabolism, March 2021, Elsevier

    Professor Deepak L Bhatt

  648. Life and limb protection with dual anti-thrombotic pathway inhibition: COMPASS ushers in a new day in atherothrombotic risk reduction

    Article • Med, March 2021, Elsevier

    Professor Deepak L Bhatt

  649. Abstract P384: Outcomes of Endovascular Therapy in Patients With Pre-Stroke Mobility Impairment

    Article • Stroke, March 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  650. Abstract 57: Reduction in Ischemic Stroke With Icosapent Ethyl - Insights From REDUCE-IT

    Article • Stroke, March 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  651. The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus

    Article • Diabetologia, February 2021, Springer Science + Business Media

    Professor Deepak L Bhatt

  652. Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial

    Article • Gut, February 2021, BMJ

    Professor Deepak L Bhatt

  653. Clinical Characteristics and Outcomes Associated With Oral Anticoagulant Use Among Patients Hospitalized With Intracerebral Hemorrhage

    Article • JAMA Network Open, February 2021, American Medical Association (AMA)

    Professor Deepak L Bhatt

  654. Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction

    Article • Journal of the American Heart Association, February 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  655. Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials

    Article • Circulation, February 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  656. Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS): a double-blind randomised placebo-controlled crossover trial

    Article • Diabetology & Metabolic Syndrome, February 2021, Springer Science + Business Media

    Professor Deepak L Bhatt

  657. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention

    Article • Circulation, February 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  658. Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity score matching analysis

    Article • European Heart Journal Acute Cardiovascular Care, February 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  659. Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease

    Article • Circulation, February 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  660. Preoperative Heart Failure Treatment Prevents Postoperative Cardiac Complications in Patients With Lower Risk

    Article • Annals of Surgery, February 2021, Wolters Kluwer Health

    John Mitchell, Professor Deepak L Bhatt

  661. 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease

    Article • Journal of the American College of Cardiology, February 2021, Elsevier

    Professor Deepak L Bhatt

  662. Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis

    Article • American Heart Journal, February 2021, Elsevier

    Professor Deepak L Bhatt

  663. Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease

    Article • Circulation Genomic and Precision Medicine, February 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  664. Meta-Analysis of Transradial vs Transfemoral Access for Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction

    Article • The American Journal of Cardiology, February 2021, Elsevier

    Professor Deepak L Bhatt

  665. Patterns of antidepressant therapy and clinical outcomes among ischaemic stroke survivors

    Article • Stroke and Vascular Neurology, February 2021, BMJ

    Professor Deepak L Bhatt

  666. Predicting 10-year risk of recurrent cardiovascular events andcardiovascular interventions in patients with established cardiovascular disease: results from UCC-SMART and REACH

    Article • International Journal of Cardiology, February 2021, Elsevier

    Professor Deepak L Bhatt

  667. Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial

    Article • Journal of the American College of Cardiology, February 2021, Elsevier

    Professor Deepak L Bhatt

  668. Underdiagnosis of Isolated Systolic and Isolated Diastolic Hypertension

    Article • The American Journal of Cardiology, February 2021, Elsevier

    Professor Deepak L Bhatt

  669. The cost‐effectiveness of dapagliflozin in treating high‐risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE‐TIMI 58 trial

    Article • Diabetes Obesity and Metabolism, January 2021, Wiley

    Professor Deepak L Bhatt

  670. Association between COVID-19 Outcomes and Mask Mandates, Adherence, and Attitudes

    Article • January 2021, Cold Spring Harbor Laboratory Press

    Professor Deepak L Bhatt

  671. Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 2021, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt, Professor Vladimir V Rafalskiy

  672. Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 2021, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt

  673. Transcatheter aortic valve replacement same-day discharge for selected patients: a case series

    Article • European Heart Journal - Case Reports, January 2021, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  674. Ultrasound-based internal carotid artery plaque characterization using deep learning paradigm on a supercomputer: a cardiovascular disease/stroke risk assessment system

    Article • The International Journal of Cardiovascular Imaging, January 2021, Springer Science + Business Media

    Professor Deepak L Bhatt

  675. Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease

    Article • JAMA, January 2021, American Medical Association (AMA)

    Professor Deepak L Bhatt

  676. Reduction in Revascularization With Icosapent Ethyl

    Article • Circulation, January 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  677. Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stent

    Article • American Heart Journal, January 2021, Elsevier

    Professor Deepak L Bhatt

  678. EPA and DHA containing phospholipids have contrasting effects on membrane structure

    Article • Journal of Lipid Research, January 2021, Elsevier

    Professor Deepak L Bhatt

  679. Is There an Optimal Antiplatelet Strategy after Gastrointestinal Bleeding in Patients with Coronary Artery Disease?

    Article • Cardiology, January 2021, Karger Publishers

    Professor Deepak L Bhatt

  680. Safety and Feasibility of Same-Day Discharge After Left Atrial Appendage Closure With the WATCHMAN Device

    Article • Circulation Cardiovascular Interventions, January 2021, Wolters Kluwer Health

    Professor Deepak L Bhatt

  681. Cardiac rehabilitation using telemedicine: the need for tele cardiac rehabilitation

    Article • Reviews in Cardiovascular Medicine, December 2020, IMR Press

    Professor Deepak L Bhatt

  682. Integration of cardiovascular risk assessment with COVID-19 using artificial intelligence

    Article • Reviews in Cardiovascular Medicine, December 2020, IMR Press

    Professor Deepak L Bhatt

  683. Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium–glucose co‐transporter 2 inhibitor therapy in DECLARE‐TIMI 58

    Article • European Journal of Heart Failure, December 2020, Wiley

    Professor Deepak L Bhatt

  684. Personal-Level Protective Actions Against Particulate Matter Air Pollution Exposure: A Scientific Statement From the American Heart Association

    Article • Circulation, December 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  685. Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery

    Article • JAMA Internal Medicine, December 2020, American Medical Association (AMA)

    Prof. Giuseppe Biondi-Zoccai, Professor Deepak L Bhatt

  686. Target: Stroke Was Associated With Faster Intravenous Thrombolysis and Improved One-Year Outcomes for Acute Ischemic Stroke in Medicare Beneficiaries

    Article • Circulation Cardiovascular Quality and Outcomes, December 2020, Wolters Kluwer Health

    Dr. Roland A. Matsouaka, Professor Deepak L Bhatt

  687. Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, December 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  688. A regional analysis of payer and provider views on cholesterol management: PCSK9 inhibitors as an illustrative alignment model

    Article • Journal of Managed Care & Specialty Pharmacy, December 2020, Academy of Managed Care Pharmacy

    Professor Deepak L Bhatt

  689. Addressing bias: artificial intelligence in cardiovascular medicine

    Article • The Lancet Digital Health, December 2020, Elsevier

    Professor Deepak L Bhatt

  690. Amyloidosis and 30-Day Outcomes Among Patients With Heart Failure

    Article • JACC CardioOncology, December 2020, Elsevier

    Professor Deepak L Bhatt

  691. Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke

    Article • International Journal of Cardiology, December 2020, Elsevier

    Professor Deepak L Bhatt

  692. Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure

    Article • Journal of the American College of Cardiology, December 2020, Elsevier

    Professor Deepak L Bhatt

  693. Cardiopulmonary Impact of Particulate Air Pollution in High-Risk Populations

    Article • Journal of the American College of Cardiology, December 2020, Elsevier

    Professor Deepak L Bhatt

  694. Early Post-Percutaneous Coronary Intervention Chest Pain: A Nationwide Survey on Interventional Cardiologists' Perspective

    Article • Cardiovascular Revascularization Medicine, December 2020, Elsevier

    Professor Deepak L Bhatt

  695. Early initiation of SGLT2 inhibitors is important, irrespective of ejection fraction: SOLOIST‐WHF in perspective

    Article • ESC Heart Failure, December 2020, Wiley

    Professor Deepak L Bhatt

  696. Quality of Care and Outcomes Among Medicare Advantage vs Fee-for-Service Medicare Patients Hospitalized With Heart Failure

    Article • JAMA Cardiology, December 2020, American Medical Association (AMA)

    Professor Deepak L Bhatt

  697. Translating the findings of ISCHEMIA into clinical practice: a challenging START

    Article • EuroIntervention, December 2020, Europa Digital & Publishing

    Professor Deepak L Bhatt

  698. Trends in Costs and Risk Factors of 30-Day Readmissions for Transcatheter Aortic Valve Implantation

    Article • The American Journal of Cardiology, December 2020, Elsevier

    Professor Deepak L Bhatt

  699. Trends in Reperfusion Therapy for In-Hospital Ischemic Stroke in the Endovascular Therapy Era

    Article • JAMA Neurology, December 2020, American Medical Association (AMA)

    Professor Deepak L Bhatt

  700. U.S. Prevalence of Individuals With Diabetes and Chronic Kidney Disease Indicated for SGLT-2 Inhibitor Therapy

    Article • Journal of the American College of Cardiology, December 2020, Elsevier

    Professor Deepak L Bhatt

  701. The association of amputations and peripheral artery disease in patients with type 2 diabetes mellitus receiving sodium-glucose cotransporter type-2 inhibitors: real-world study

    Article • European Heart Journal, November 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  702. Abstract 16327: Clinical Profiles, Care Patterns, Outcomes and Sex Differences of Patients With STEMI in India: Insights From the North Indian ST-segment Elevation Myocardial Infarction (NORIN STEMI) Registry

    Article • Circulation, November 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  703. Abstract 15019: Differential Effects of Omega-3 Fatty Acid Combinations on the Inhibition of Oxidation Of Human Low-density Lipoproteins in vitro

    Article • Circulation, November 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  704. Abstract 15015: Eicosapentaenoic Acid, but Not Docosahexaenoic Acid or a Mixed Omega-3 Fatty Acid Supplement, Inhibits Low-density Lipoprotein Oxidation in a Time-dependent Manner

    Article • Circulation, November 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  705. Abstract 14961: External Applicability of REDUCE-IT in a Large Diabetes Cardiovascular Outcomes Trial: A Post Hoc Analysis of EMPA-REG OUTCOME

    Article • Circulation, November 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  706. Abstract 14997: Icosapent Ethyl Reduces Ischemic Events in Patients With Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG

    Article • Circulation, November 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  707. Abstract 14073: Omega-3 Fatty Acid Levels and Risk for Incident Bleeding and Atrial Fibrillation: Multi-Ethnic Study of Atherosclerosis (MESA)

    Article • Circulation, November 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  708. Abstract 16749: Prevalence, Predictors, and Prognostic Implications of Left Ventricular Systolic Dysfunction Among Patients With STEMI in India: The Prospective NORIN-STEMI Registry

    Article • Circulation, November 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  709. Abstract 15091: Significant Reductions in Both Adjudicated and Investigator-Reported Ischemic Events in REDUCE-IT

    Article • Circulation, November 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  710. Abstract 15913: Two-year Results of the Getting to an Improved Understanding of Low-density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) Registry of Patients With Atherosclerotic Cardiovascular Disease (ASCVD)

    Article • Circulation, November 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  711. Abstract 13214: Underuse of Combination Pharmacotherapy for Management of Dyslipidemia versus Diabetes and Hypertension Among Patients With Atherosclerotic Cardiovascular Disease (ascvd): Insights From the Getting to an Improved Understanding of Low-de...

    Article • Circulation, November 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  712. Outcomes of Medicare beneficiaries hospitalised with transient ischaemic attack and stratification using the ABCD2 score

    Article • Stroke and Vascular Neurology, November 2020, BMJ

    Professor Deepak L Bhatt

  713. Three-Year Outcomes of Bariatric Surgery in Patients With Obesity and Hypertension

    Article • Annals of Internal Medicine, November 2020, American College of Physicians

    Professor Deepak L Bhatt

  714. Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis

    Article • Thrombosis Research, November 2020, Elsevier

    Prof HECTOR BUENO, Dr Tuomas O Kiviniemi, Professor Deepak L Bhatt

  715. A Revolution in Omega-3 Fatty Acid Research

    Article • Journal of the American College of Cardiology, November 2020, Elsevier

    Professor Deepak L Bhatt

  716. Advanced cardiometabolic & inflammatory markers for prediction of cardiovascular disease and cancer

    Article • European Heart Journal, November 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  717. Aortic Valve Replacement in Bioprosthetic Failure: Insights From The Society of Thoracic Surgeons National Database

    Article • The Annals of Thoracic Surgery, November 2020, Elsevier

    Professor Deepak L Bhatt

  718. Applying to Medical School in the COVID-19 Era

    Article • Mayo Clinic Proceedings, November 2020, Elsevier

    Professor Deepak L Bhatt

  719. Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines

    Article • JAMA Cardiology, November 2020, American Medical Association (AMA)

    Professor Deepak L Bhatt

  720. Comparison of Dabigatran Plus a P2Y12 Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI

    Article • The American Journal of Medicine, November 2020, Elsevier

    Professor Deepak L Bhatt

  721. Complete revascularization for patients with multivessel coronary artery disease and ST-segment elevation myocardial infarction after the COMPLETE trial: a meta-analysis of randomized controlled trial

    Article • European Heart Journal, November 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  722. Confounding Factors in Renal Denervation Trials

    Article • Hypertension, November 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  723. Effect of alirocumab on incidence of atrial fibrillation after acute coronary syndromes: insights from ODYSSEY OUTCOMES

    Article • European Heart Journal, November 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  724. Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial

    Article • European Heart Journal, November 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  725. Necessity of 45-Day Transesophageal Echocardiography After the WATCHMAN Procedure Amid the COVID-19 Pandemic

    Article • JACC Cardiovascular Imaging, November 2020, Elsevier

    Professor Deepak L Bhatt

  726. New Decade, New FDA Guidance for Diabetes Drug Development

    Article • Journal of the American College of Cardiology, November 2020, Elsevier

    Professor Deepak L Bhatt

  727. Regulation of Cardiovascular Therapies During the COVID-19 Public Health Emergency

    Article • Journal of the American College of Cardiology, November 2020, Elsevier

    Professor Deepak L Bhatt

  728. The effect of elevated triglycerides and purified eicosapentaenoic acid ethyl ester (EPA) for cardiovascular risk reduction in the UK Biobank population

    Article • European Heart Journal, November 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  729. The Road to Approval: a Perspective on the Role of Icosapent Ethyl in Cardiovascular Risk Reduction

    Article • Current Diabetes Reports, October 2020, Springer Science + Business Media

    Professor Deepak L Bhatt

  730. Lifelong Aspirin for All in the Secondary Prevention of Chronic Coronary Syndrome

    Article • Circulation, October 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  731. Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial

    Article • European Heart Journal, October 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  732. Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents

    Article • Circulation, October 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  733. Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG-MI registry

    Article • European Heart Journal, October 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  734. Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus‐eluting stents

    Article • Catheterization and Cardiovascular Interventions, October 2020, Wiley

    Professor Deepak L Bhatt

  735. Randomized, Controlled Trial Comparing Mitral Valve Repair With Leaflet Resection Versus Leaflet Preservation on Functional Mitral Stenosis

    Article • Circulation, October 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  736. REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final results

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, October 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  737. Beyond cardiovascular medicine: potential future uses of icosapent ethyl

    Article • European Heart Journal Supplements, October 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  738. Mechanisms of action, efficacy, and safety of icosapent ethyl: from bench to bedside

    Article • European Heart Journal Supplements, October 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  739. Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies

    Article • European Heart Journal Supplements, October 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  740. Clinical characteristics and outcomes of COMPASS eligible patients in France. An analysis from the REACH Registry

    Article • Annales de Cardiologie et d Angéiologie, October 2020, Elsevier

    Professor Deepak L Bhatt

  741. Incidence, Characteristics, Predictors, and Outcomes of Surgical Explantation After Transcatheter Aortic Valve Replacement

    Article • Journal of the American College of Cardiology, October 2020, Elsevier

    Professor Deepak L Bhatt

  742. Reply

    Article • JACC Cardiovascular Interventions, October 2020, Elsevier

    Professor Deepak L Bhatt

  743. Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018

    Article • JAMA Internal Medicine, October 2020, American Medical Association (AMA)

    Professor Deepak L Bhatt

  744. Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline

    Article • Stroke, October 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  745. Cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from DECLARE‐TIMI 58

    Article • Diabetes Obesity and Metabolism, September 2020, Wiley

    Professor Deepak L Bhatt

  746. Impact of Expanded FDA Indication for Icosapent Ethyl On Enhanced Cardiovascular Residual Risk Reduction

    Article • Future Cardiology, September 2020, Taylor & Francis

    Professor Deepak L Bhatt

  747. The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID‐19

    Article • Journal of the American Heart Association, September 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  748. Generalizability of Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial in patients with a history of coronary artery bypass graft surgery

    Article • Current Opinion in Cardiology, September 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  749. Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: Design and rationale of the Mass General Brigham Lp(a) Registry

    Article • Clinical Cardiology, September 2020, Wiley

    Professor Deepak L Bhatt

  750. Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials

    Article • Diabetes Obesity and Metabolism, September 2020, Wiley

    Professor Deepak L Bhatt

  751. Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System

    Article • Cardiovascular Drugs and Therapy, September 2020, Springer Science + Business Media

    Professor Deepak L Bhatt

  752. “Cholesterol-Years” for ASCVD Risk Prediction and Treatment

    Article • Journal of the American College of Cardiology, September 2020, Elsevier

    Professor Deepak L Bhatt

  753. A questionnaire survey for improving awareness of rheumatic heart disease among school-aged children in India

    Article • Indian Heart Journal, September 2020, Elsevier

    Professor Deepak L Bhatt

  754. Artificial intelligence in medical imaging: switching from radiographic pathological data to clinically meaningful endpoints

    Article • The Lancet Digital Health, September 2020, Elsevier

    Professor Deepak L Bhatt

  755. Effects of the COVID-19 Pandemic on Active Non-COVID Clinical Trials

    Article • Journal of the American College of Cardiology, September 2020, Elsevier

    Professor Deepak L Bhatt

  756. Influence of Influenza Infection on In-Hospital Acute Myocardial Infarction Outcomes

    Article • The American Journal of Cardiology, September 2020, Elsevier

    Professor Deepak L Bhatt

  757. Abstract P233: Inhibition Of Aldosterone Synthesis In Non-human Primates By PB6440, The Novel Highly Selective And Potent CYP11B2 Inhibitor

    Article • Hypertension, September 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  758. Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization

    Article • Circulation Cardiovascular Quality and Outcomes, September 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  759. Prevalence and Outcomes of Acute Ischemic Stroke Among Patients ≤50 Years of Age With Laboratory Confirmed COVID-19 Infection

    Article • The American Journal of Cardiology, September 2020, Elsevier

    Professor Deepak L Bhatt

  760. Reply

    Article • Journal of the American College of Cardiology, September 2020, Elsevier

    Professor Deepak L Bhatt

  761. Secondary prevention of cardiovascular diseases in India: Findings from registries and large cohorts

    Article • Indian Heart Journal, September 2020, Elsevier

    Professor Deepak L Bhatt

  762. Self-employment and cardiovascular risk in the US general population

    Article • International Journal of Cardiology Hypertension, September 2020, Elsevier

    Professor Deepak L Bhatt

  763. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial

    Article • The Lancet, September 2020, Elsevier

    Professor Deepak L Bhatt

  764. Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review

    Article • Progress in Cardiovascular Diseases, September 2020, Elsevier

    Professor Deepak L Bhatt

  765. TAVR and the Kidney

    Article • Journal of the American College of Cardiology, September 2020, Elsevier

    Professor Deepak L Bhatt

  766. The COVID-19 pandemic: a catalyst to improve clinical trials

    Article • Nature Reviews Cardiology, September 2020, Springer Science + Business Media

    Professor Deepak L Bhatt

  767. Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI

    Article • Journal of the American College of Cardiology, September 2020, Elsevier

    Professor Deepak L Bhatt

  768. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

    Article • European Heart Journal, August 2020, Oxford University Press (OUP)

    Prof HECTOR BUENO, Professor Deepak L Bhatt

  769. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial

    Article • European Heart Journal, August 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  770. Intensive blood pressure control appears to be effective and safe in patients with peripheral artery disease: the Systolic Blood Pressure Intervention Trial

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, August 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  771. Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58

    Article • Circulation, August 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  772. Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial

    Article • European Heart Journal, August 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  773. Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy

    Article • European Journal of Heart Failure, August 2020, Wiley

    Professor Deepak L Bhatt

  774. Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography

    Article • Journal of Clinical Hypertension, August 2020, Wiley

    Professor Deepak L Bhatt

  775. Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis

    Article • Journal of the American Heart Association, August 2020, Wolters Kluwer Health

    MD Antonio Greco, Professor Deepak L Bhatt

  776. Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers

    Article • JAMA, August 2020, American Medical Association (AMA)

    Professor Deepak L Bhatt

  777. Effects of Epeleuton, a Novel Synthetic Second‐Generation n‐3 Fatty Acid, on Non‐Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers

    Article • Journal of the American Heart Association, August 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  778. Genetic Variation in Cardiometabolic Traits and Medication Targets and the Risk of Hypertensive Disorders of Pregnancy

    Article • Circulation, August 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  779. Infective Endocarditis After Surgical and Transcatheter Aortic Valve Replacement: A State of the Art Review

    Article • Journal of the American Heart Association, August 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt, Dr Aaqib H Malik

  780. Impact of chronic kidney disease on in‐hospital outcomes and readmission rate after edge‐to‐edge transcatheter mitral valve repair

    Article • Catheterization and Cardiovascular Interventions, August 2020, Wiley

    Professor Deepak L Bhatt

  781. An Optimized Approach for Transfemoral Transcatheter Aortic Valve Implantation: A Comprehensive Review and Current Evidence

    Article • Cardiovascular Revascularization Medicine, August 2020, Elsevier

    Professor Deepak L Bhatt

  782. Clinical features and prognosis of patients with spontaneous coronary artery dissection

    Article • International Journal of Cardiology, August 2020, Elsevier

    Professor Deepak L Bhatt

  783. Complete revascularization for patients with multivessel coronary artery disease and ST-segment elevation myocardial infarction after the COMPLETE trial: A meta-analysis of randomized controlled trials

    Article • IJC Heart & Vasculature, August 2020, Elsevier

    Professor Deepak L Bhatt

  784. Federal judge invalidates icosapent ethyl patents — but on the basis of a common statistical mistake

    Article • Nature Biotechnology, August 2020, Springer Science + Business Media

    Professor Deepak L Bhatt

  785. Quantifying the Impact of Care Fragmentation on Outcomes After Transcatheter Aortic Valve Implantation

    Article • The American Journal of Cardiology, August 2020, Elsevier

    Professor Deepak L Bhatt

  786. Randomized Trials Versus Common Sense and Clinical Observation

    Article • Journal of the American College of Cardiology, August 2020, Elsevier

    Professor Deepak L Bhatt

  787. Sex Differences in Case Fatality Rate of COVID-19: Insights From a Multinational Registry

    Article • Mayo Clinic Proceedings, August 2020, Elsevier

    Professor Deepak L Bhatt

  788. Abstract 335: Distinct Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid Linked Phospholipids on Membrane Structure

    Article • Circulation Research, July 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  789. Abstract 318: Eicosapentaenoic Acid Improved Nitric Oxide Bioavailability and Reduced Nitroxidative Stress in Human Endothelial Cells in Contrast to Arachidonic Acid In Vitro

    Article • Circulation Research, July 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  790. Long‐term predictive value of stroke volume index obtained from right heart catheterization: Insights from the veterans affairs clinical assessment, reporting, and tracking program

    Article • Clinical Cardiology, July 2020, Wiley

    Professor Deepak L Bhatt

  791. Intensive vs. standard blood pressure control and vascular procedures: insights from the Systolic Blood Pressure Intervention Trial (SPRINT)

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, July 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  792. Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial

    Article • European Journal of Preventive Cardiology, July 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  793. Association of Smoking Cessation and Survival Among Young Adults With Myocardial Infarction in the Partners YOUNG-MI Registry

    Article • JAMA Network Open, July 2020, American Medical Association (AMA)

    Professor Deepak L Bhatt

  794. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results

    Article • Cardiovascular Research, July 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  795. Association Between the Framingham Risk Score and Carotid Artery Intima-Media Thickness in Patients With Human Immunodeficiency Virus

    Article • The American Journal of Cardiology, July 2020, Elsevier

    Professor Deepak L Bhatt

  796. Association of high-density lipoprotein levels with baseline coronary plaque volumes by coronary CTA in the EVAPORATE trial

    Article • Atherosclerosis, July 2020, Elsevier

    Professor Deepak L Bhatt

  797. Differential effect of ticagrelor on irreversible harms in diabetes – Authors' reply

    Article • The Lancet, July 2020, Elsevier

    Professor Deepak L Bhatt

  798. Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic

    Article • Journal of the American College of Cardiology, July 2020, Elsevier

    Professor Deepak L Bhatt

  799. Long-Term Outcomes With Drug-Eluting Stents or Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Disease: A Meta-Analysis and Trial Sequential Analysis of Randomized Trials

    Article • The American Journal of Cardiology, July 2020, Elsevier

    Professor Deepak L Bhatt

  800. Management of acute myocardial injury in patients with confirmed or suspected COVID-19

    Article • Atherosclerosis, July 2020, Elsevier

    Professor Deepak L Bhatt

  801. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease

    Article • JACC Cardiovascular Interventions, July 2020, Elsevier

    Professor Deepak L Bhatt

  802. Palliative Care Utilization Among Patients With Critical Limb Ischemia

    Article • JACC Cardiovascular Interventions, July 2020, Elsevier

    Professor Deepak L Bhatt

  803. Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction

    Article • JAMA Cardiology, July 2020, American Medical Association (AMA)

    Professor Deepak L Bhatt

  804. Pregnancy as a Cardiac Stress Test

    Article • Journal of the American College of Cardiology, July 2020, Elsevier

    Professor Deepak L Bhatt

  805. Reply

    Article • Journal of the American College of Cardiology, July 2020, Elsevier

    Professor Deepak L Bhatt

  806. Sleep Duration and Cardiovascular Health in a Representative Community Population (from NHANES, 2005 to 2016)

    Article • The American Journal of Cardiology, July 2020, Elsevier

    Professor Deepak L Bhatt

  807. The Consequences of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials

    Article • Journal of the American College of Cardiology, July 2020, Elsevier

    Professor Deepak L Bhatt

  808. Atherosclerotic cardiovascular disease risk and elevated lipoprotein(a) among young adults with myocardial infarction: The Partners YOUNG-MI Registry

    Article • European Journal of Preventive Cardiology, June 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  809. Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial

    Article • Drugs, June 2020, Springer Science + Business Media

    Professor Deepak L Bhatt

  810. Resource and Infrastructure-Appropriate Management of ST-Segment Elevation Myocardial Infarction in Low- and Middle-Income Countries

    Article • Circulation, June 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  811. Self-treatment for acute coronary syndrome: why not?

    Article • European Heart Journal, June 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  812. Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease

    Article • Circulation, June 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  813. Periodontal Inflammation and the Risk of Cardiovascular Disease

    Article • Current Atherosclerosis Reports, June 2020, Springer Science + Business Media

    Professor Deepak L Bhatt

  814. Evaluation of the Switch From Amiodarone to Dronedarone in Patients With Atrial Fibrillation: Results of the ARTEMIS AF Studies

    Article • Journal of Cardiovascular Pharmacology and Therapeutics, June 2020, SAGE Publications

    Professor Deepak L Bhatt

  815. The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials

    Article • Diabetes Obesity and Metabolism, June 2020, Wiley

    Professor Deepak L Bhatt

  816. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke

    Article • JAMA, June 2020, American Medical Association (AMA)

    Professor Deepak L Bhatt

  817. 1101-P: Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents: Analyses from DECLARE-TIMI 58

    Article • Diabetes, June 2020, American Diabetes Association

    Professor Deepak L Bhatt

  818. 1429-P: Use of Guideline-Recommended Risk-Reduction Strategies among Patients with Type 2 Diabetes and Established ASCVD: A 1-Year Update from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD)

    Article • Diabetes, June 2020, American Diabetes Association

    Professor Deepak L Bhatt

  819. 303-OR: Effect of Dapagliflozin on Risk for Fast Decline in EGFR: Analyses from the DECLARE-TIMI 58 Trial

    Article • Diabetes, June 2020, American Diabetes Association

    Professor Deepak L Bhatt

  820. 4-LB: Substantial Cardiovascular Benefit from Icosapent Ethyl in Patients with Diabetes: REDUCE-IT DIABETES

    Article • Diabetes, June 2020, American Diabetes Association

    Professor Deepak L Bhatt

  821. 403-P: Impact of Diabetes-Related Factors and Background Antihyperglycemic Therapy on the Efficacy and Safety of Ticagrelor Added to Aspirin: Insights from the THEMIS Trial

    Article • Diabetes, June 2020, American Diabetes Association

    Prof HECTOR BUENO, Professor Deepak L Bhatt

  822. Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials

    Article • JAMA Cardiology, June 2020, American Medical Association (AMA)

    Professor Deepak L Bhatt

  823. Population-based long-term outcomes of open versus endovascular aortic repair of ruptured abdominal aortic aneurysms

    Article • Journal of Vascular Surgery, June 2020, Elsevier

    Professor Deepak L Bhatt

  824. Recovery of Left Ventricular Systolic Function and Clinical Outcomes in Young Adults With Myocardial Infarction

    Article • Journal of the American College of Cardiology, June 2020, Elsevier

    Professor Deepak L Bhatt

  825. Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

    Article • Journal of the American College of Cardiology, June 2020, Elsevier

    Professor Deepak L Bhatt

  826. The Early Bird Catches the Worm

    Article • JACC Cardiovascular Interventions, June 2020, Elsevier

    Professor Deepak L Bhatt

  827. Response by Bhatt et al to Letter Regarding Article, “REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States”

    Article • Circulation, May 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  828. Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome

    Article • Circulation, May 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  829. Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS‐TIMI 54 Trial

    Article • Journal of the American Heart Association, May 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  830. Gut Microbiota‐Dependent Trimethylamine N‐oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS‐TIMI 54 Trial

    Article • Journal of the American Heart Association, May 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  831. Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association

    Article • Circulation, May 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  832. Rural-Urban Differences in Cardiovascular Mortality in the US, 1999-2017

    Article • JAMA, May 2020, American Medical Association (AMA)

    Professor Deepak L Bhatt

  833. Closing Gaps in Essential Chest Pain Care Through Accreditation

    Article • Journal of the American College of Cardiology, May 2020, Elsevier

    Professor Deepak L Bhatt

  834. Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure Risk

    Article • The American Journal of Cardiology, May 2020, Elsevier

    Professor Deepak L Bhatt

  835. Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes

    Article • Journal of the American College of Cardiology, May 2020, Elsevier

    Professor Deepak L Bhatt

  836. Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid

    Article • Arteriosclerosis Thrombosis and Vascular Biology, May 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  837. Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

    Article • JAMA Cardiology, May 2020, American Medical Association (AMA)

    Professor Deepak L Bhatt

  838. Performance in Federal Value-Based Programs of Hospitals Recognized by the American Heart Association and American College of Cardiology for High-Quality Heart Failure and Acute Myocardial Infarction Care

    Article • JAMA Cardiology, May 2020, American Medical Association (AMA)

    Professor Deepak L Bhatt

  839. Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry

    Article • The American Journal of Medicine, May 2020, Elsevier

    Professor Deepak L Bhatt

  840. Vascular Risk Reduction in Obesity through Reduced Granulocyte Burden and Improved Angiogenic Monocyte Content following Bariatric Surgery

    Article • Cell Reports Medicine, May 2020, Elsevier

    Professor Deepak L Bhatt

  841. Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE‐TIMI 58 study

    Article • Diabetes Obesity and Metabolism, April 2020, Wiley

    Professor Deepak L Bhatt

  842. Twitter-based learning for continuing medical education?

    Article • European Heart Journal, April 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  843. Adherence to Guideline Medication Recommendations to Prevent Atherosclerotic Cardiovascular Disease Progression Among Adults With Prior Myocardial Infarction

    Article • JAMA Network Open, April 2020, American Medical Association (AMA)

    Professor Deepak L Bhatt

  844. Prevalence of Multiplicity and Appropriate Adjustments Among Cardiovascular Randomized Clinical Trials Published in Major Medical Journals

    Article • JAMA Network Open, April 2020, American Medical Association (AMA)

    Professor Deepak L Bhatt

  845. Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus

    Article • Circulation, April 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  846. Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval Studies

    Article • Journal of the American Heart Association, April 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  847. Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI)

    Article • Circulation, April 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  848. Bariatric Surgery Improves HDL Function Examined by ApoA1 Exchange Rate and Cholesterol Efflux Capacity in Patients with Obesity and Type 2 Diabetes

    Article • Biomolecules, April 2020, MDPI AG

    Professor Deepak L Bhatt

  849. Association of Outpatient Practice-Level Socioeconomic Disadvantage With Quality of Care and Outcomes Among Older Adults With Coronary Artery Disease

    Article • Circulation Cardiovascular Quality and Outcomes, April 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  850. Bedscales: A non-contact adherence-independent multi-person sensor for longitudinal physiologic monitoring in the home bed

    Article • April 2020, Cold Spring Harbor Laboratory Press

    Professor Deepak L Bhatt

  851. Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention

    Article • Circulation Cardiovascular Interventions, April 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  852. IgM Antibodies with atheroprotective properties in heart transplants are IgM anti‐phosphorylcholine

    Article • The FASEB Journal, April 2020, Wiley

    Professor Deepak L Bhatt

  853. The Reply

    Article • The American Journal of Medicine, April 2020, Elsevier

    Professor Deepak L Bhatt

  854. No Significant Relationship Between Ticagrelor and Sleep Apnea in Large, Randomized, Blinded Trials

    Article • JACC Cardiovascular Interventions, April 2020, Elsevier

    Professor Deepak L Bhatt

  855. Randomized Trials in Cardiac Surgery

    Article • Journal of the American College of Cardiology, April 2020, Elsevier

    Professor Deepak L Bhatt

  856. Response by Latif et al to Letter Regarding Article, "Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial"

    Article • Circulation Cardiovascular Interventions, April 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  857. Systematic review and meta-analysis of current risk models in predicting short-term mortality after transcatheter aortic valve replacement

    Article • EuroIntervention, April 2020, Europa Digital & Publishing

    Professor Deepak L Bhatt

  858. Are statins back for patients on hemodialysis?

    Article • European Journal of Preventive Cardiology, March 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  859. Association between uric acid levels and cardio‐renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA‐REG OUTCOME

    Article • Diabetes Obesity and Metabolism, March 2020, Wiley

    Professor Deepak L Bhatt

  860. Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk

    Article • Circulation, March 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  861. Targeting cardiovascular inflammation: next steps in clinical translation

    Article • European Heart Journal, March 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  862. Cardiovascular and renal benefits of dapagliflozin in patients with short and long‐standing type 2 diabetes: Analysis from the DECLARE‐TIMI 58 trial

    Article • Diabetes Obesity and Metabolism, March 2020, Wiley

    Professor Deepak L Bhatt

  863. Looking into the next decade of antithrombotic therapy for patients with atrial fibrillation and percutaneous coronary intervention

    Article • Journal of Thrombosis and Thrombolysis, March 2020, Springer Science + Business Media

    Professor Deepak L Bhatt

  864. The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial

    Article • Nephrology Dialysis Transplantation, March 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  865. Abstract P108: Cardiovascular Health Awareness and the Effect of an Educational Intervention on School-aged Children in Calcutta, India

    Article • Circulation, March 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  866. A LEADER in the management of type 2 diabetes and cardiorenal disease

    Article • Journal of Thoracic and Cardiovascular Surgery, March 2020, Elsevier

    Professor Deepak L Bhatt

  867. Cardiovascular Mortality After Type 1 and Type 2 Myocardial Infarction in Young Adults

    Article • Journal of the American College of Cardiology, March 2020, Elsevier

    Professor Deepak L Bhatt

  868. Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer

    Article • JACC CardioOncology, March 2020, Elsevier

    Professor Deepak L Bhatt

  869. Contrast-Associated Acute Kidney Injury and Serious Adverse Outcomes Following Angiography

    Article • Journal of the American College of Cardiology, March 2020, Elsevier

    Professor Deepak L Bhatt

  870. Coronary Embolism: A Systematic Review

    Article • Cardiovascular Revascularization Medicine, March 2020, Elsevier

    Professor Deepak L Bhatt

  871. EFFECTS OF DAPAGLIFLOZIN ON CARDIOVASCULAR OUTCOMES ACROSS BODY MASS INDEX CATEGORIES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN THE DECLARE TIMI 58 TRIAL

    Article • Journal of the American College of Cardiology, March 2020, Elsevier

    Professor Deepak L Bhatt

  872. Reply

    Article • JACC Cardiovascular Interventions, March 2020, Elsevier

    Professor Deepak L Bhatt

  873. SEX AND PERMANENT DRUG DISCONTINUATION IN CLINICAL TRIALS: INSIGHTS FROM THE TIMI TRIALS

    Article • Journal of the American College of Cardiology, March 2020, Elsevier

    Professor Deepak L Bhatt

  874. Selective Autoretroperfusion Provides Substantial Cardioprotection in Swine

    Article • JACC Basic to Translational Science, March 2020, Elsevier

    Professor Deepak L Bhatt

  875. The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension

    Article • Biochemical and Biophysical Research Communications, March 2020, Elsevier

    Professor Deepak L Bhatt

  876. Meta‐analysis of bivalirudin versus heparin in transradial coronary interventions

    Article • Catheterization and Cardiovascular Interventions, February 2020, Wiley

    Professor Deepak L Bhatt

  877. Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulation

    Article • Journal of Thrombosis and Thrombolysis, February 2020, Springer Science + Business Media

    Professor Deepak L Bhatt

  878. Incidental Imaging Findings in Clinical Trials

    Article • JAMA, February 2020, American Medical Association (AMA)

    Professor Deepak L Bhatt

  879. Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure

    Article • US Cardiology Review, February 2020, Medical Media Communications, Ltd. T/A Radcliffe Cardiology

    Professor Deepak L Bhatt

  880. REDUCE-IT USA

    Article • Circulation, February 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  881. Continued Evolution of Renal Artery Denervation for Hypertension

    Article • JACC Cardiovascular Interventions, February 2020, Elsevier

    Professor Deepak L Bhatt

  882. Interventions for Secondary Mitral Regurgitation in Patients With Heart Failure: A Network Meta-Analysis of Randomized Controlled Comparisons of Surgery, Medical Therapy and Transcatheter Intervention

    Article • Cardiovascular Revascularization Medicine, February 2020, Elsevier

    Professor Deepak L Bhatt

  883. Meta-Analysis of Transcatheter Aortic Valve Replacement in Low-Risk Patients

    Article • The American Journal of Medicine, February 2020, Elsevier

    Professor Deepak L Bhatt

  884. On the Pearls and Perils of Sub-Subspecialization

    Article • The American Journal of Medicine, February 2020, Elsevier

    Professor Deepak L Bhatt

  885. Recurrent spontaneous coronary artery dissection in the United States

    Article • International Journal of Cardiology, February 2020, Elsevier

    Professor Deepak L Bhatt

  886. Running thin: implications of a heparin shortage

    Article • The Lancet, February 2020, Elsevier

    Professor Deepak L Bhatt

  887. Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention

    Article • Circulation Cardiovascular Interventions, February 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  888. Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES

    Article • Journal of the American College of Cardiology, February 2020, Elsevier

    Professor Deepak L Bhatt

  889. Response by Bergmark et al to Letter Regarding Article, “Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial”

    Article • Circulation, January 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  890. Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease

    Article • Nature Reviews Cardiology, January 2020, Springer Science + Business Media

    Professor Deepak L Bhatt

  891. P34 The effect of sex on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial

    Article • European Heart Journal, January 2020, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  892. Comparison of Incidence and Outcomes of Cardiogenic Shock Complicating Posterior (Inferior) Versus Anterior ST-elevation Myocardial Infarction

    Article • The American Journal of Cardiology, January 2020, Elsevier

    Professor Deepak L Bhatt

  893. Does Interleukin-17A Blockade Have a Potential Clinical Role to Reduce Cardiovascular Risk in Psoriasis?

    Article • Canadian Journal of Cardiology, January 2020, Elsevier

    Professor Deepak L Bhatt

  894. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

    Article • Journal of the American College of Cardiology, January 2020, Elsevier

    Professor Thomas Munzel or Muenzel, Professor Deepak L Bhatt

  895. Characteristics, results, and reporting of contemporary surgical trials: A systematic review and analysis

    Article • International Journal of Surgery Protocols, January 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  896. Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post PCI in Patients With Atrial Fibrillation

    Article • Journal of the American College of Cardiology, January 2020, Elsevier

    Professor Deepak L Bhatt

  897. Alirocumab in Polyvascular Atherosclerotic Disease

    Article • Journal of the American College of Cardiology, January 2020, Elsevier

    Professor Deepak L Bhatt

  898. Federal Judge Invalidates Icosapent Ethyl Patents – But Based on a Common Statistical Mistake

    Article • SSRN Electronic Journal, January 2020, Elsevier

    Professor Deepak L Bhatt

  899. Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States

    Article • American Heart Journal, January 2020, Elsevier

    Professor Deepak L Bhatt

  900. Analysis : Intravascular Devices with a Higher Risk of Polymer Emboli: The Need for Particulate Generation Testing

    Article • Biomedical Instrumentation & Technology, January 2020, Association for the Advancement of Medical Instrumentation (AAMI)

    Professor Deepak L Bhatt

  901. Low-cost preventive screening using carotid ultrasound in patients with diabetes

    Article • Frontiers in Bioscience, January 2020, IMR Press

    Professor Deepak L Bhatt

  902. Marijuana Use in Patients With Cardiovascular Disease

    Article • Journal of the American College of Cardiology, January 2020, Elsevier

    Professor Deepak L Bhatt

  903. Palliative Care Use in Patients With Acute Myocardial Infarction

    Article • Journal of the American College of Cardiology, January 2020, Elsevier

    Professor Deepak L Bhatt

  904. Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months

    Article • Circulation Cardiovascular Quality and Outcomes, January 2020, Wolters Kluwer Health

    Professor Deepak L Bhatt

  905. Global perspective on carotid intima-media thickness and plaque: should the current measurement guidelines be revisited?

    Article • International Angiology, January 2020, Edizioni Minerva Medica

    Professor Deepak L Bhatt

  906. Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease

    Article • JAMA, December 2019, American Medical Association (AMA)

    Professor Deepak L Bhatt

  907. Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics

    Article • European Heart Journal, December 2019, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  908. Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES

    Article • Circulation, December 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  909. Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE–TIMI 58 Study

    Article • Diabetes Care, December 2019, American Diabetes Association

    Avivit Cahn, Professor Deepak L Bhatt

  910. Antithrombotic therapy for chronic coronary syndrome and atrial fibrillation: less might be more

    Article • Journal of Thrombosis and Thrombolysis, December 2019, Springer Science + Business Media

    Professor Deepak L Bhatt

  911. Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Per...

    Article • The American Journal of Cardiology, December 2019, Elsevier

    Professor Deepak L Bhatt

  912. Strict versus Lenient versus Poor Rate Control Among Patients with Atrial Fibrillation and Heart Failure (From the Get With The Guidelines – Heart Failure Program)

    Article • The American Journal of Cardiology, December 2019, Elsevier

    Professor Deepak L Bhatt

  913. Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation

    Article • JACC Cardiovascular Interventions, December 2019, Elsevier

    Professor Dmitry Zateyshchikov, Professor Deepak L Bhatt

  914. Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post–PCI in Patients With Atrial Fibrillation and Diabetes

    Article • JACC Cardiovascular Interventions, December 2019, Elsevier

    Professor Deepak L Bhatt

  915. Long-Term Cardiovascular Risk in Women With Hypertension During Pregnancy

    Article • Journal of the American College of Cardiology, December 2019, Elsevier

    Professor Deepak L Bhatt

  916. Temporal Trends and Outcomes of Transcatheter Mitral Valve Repair and Surgical Mitral Valve Intervention in Patients With Prior CABG

    Article • JACC Cardiovascular Interventions, December 2019, Elsevier

    Professor Deepak L Bhatt

  917. The changing landscape of aortic valve replacement in the USA

    Article • EuroIntervention, December 2019, Europa Digital & Publishing

    Professor Deepak L Bhatt

  918. Minding the Gaps in Post-Myocardial Infarction Mortality Between Sweden and the UK

    Article • Cardiovascular Research, November 2019, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  919. Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

    Article • Circulation, November 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  920. Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis

    Article • European Heart Journal, November 2019, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  921. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

    Article • Circulation, November 2019, Wolters Kluwer Health

    Professor Thomas Munzel or Muenzel, Professor Deepak L Bhatt

  922. Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus

    Article • Circulation, November 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  923. THEMIS and THEMIS-PCI

    Article • European Heart Journal, November 2019, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  924. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

    Article • Circulation Cardiovascular Quality and Outcomes, November 2019, Wolters Kluwer Health

    Professor Thomas Munzel or Muenzel, Professor Deepak L Bhatt

  925. Antiarrhythmic Drugs or Catheter Ablation in the Management of Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter-Defibrillators

    Article • Circulation Arrhythmia and Electrophysiology, November 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  926. Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes

    Article • JAMA Cardiology, November 2019, American Medical Association (AMA)

    Professor Deepak L Bhatt

  927. Cardiometabolic risk reduction after metabolic surgery

    Article • Current Opinion in Cardiology, November 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  928. Cardiovascular risk reduction with icosapent ethyl

    Article • Current Opinion in Cardiology, November 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  929. Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation Post-PCI

    Article • Journal of the American College of Cardiology, November 2019, Elsevier

    Professor Deepak L Bhatt

  930. Stability After Initial Decline in Coronary Revascularization Rates in the United States

    Article • The Annals of Thoracic Surgery, November 2019, Elsevier

    Professor Deepak L Bhatt

  931. The DAPA-HF Trial: A Momentous Victory in the War against Heart Failure

    Article • Cell Metabolism, November 2019, Elsevier

    Professor Deepak L Bhatt

  932. Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis

    Article • Circulation, October 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  933. More CREDENCE for SGLT2 Inhibition

    Article • Circulation, October 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  934. Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 2019, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt

  935. Trends in the Use of Short-Term Mechanical Circulatory Support in the United States – An Analysis of the 2012 – 2015 National Inpatient Sample

    Article • Structural Heart, October 2019, Taylor & Francis

    Professor Deepak L Bhatt

  936. Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial

    Article • European Journal of Preventive Cardiology, October 2019, SAGE Publications

    Thomas Vanassche, Professor Deepak L Bhatt

  937. Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis

    Article • BMJ, October 2019, BMJ

    Professor Deepak L Bhatt

  938. Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease

    Article • JAMA, October 2019, American Medical Association (AMA)

    Professor Deepak L Bhatt

  939. Design and rationale of the North Indian ST‐Segment Elevation Myocardial Infarction Registry: A prospective cohort study

    Article • Clinical Cardiology, October 2019, Wiley

    Professor Deepak L Bhatt

  940. Cardiovascular Toxicities of Immune Checkpoint Inhibitors

    Article • Journal of the American College of Cardiology, October 2019, Elsevier

    Dr Gopal Chandra Ghosh, Professor Deepak L Bhatt

  941. A low-cost machine learning-based cardiovascular/stroke risk assessment system: integration of conventional factors with image phenotypes

    Article • Cardiovascular Diagnosis and Therapy, October 2019, AME Publishing Company

    Professor Deepak L Bhatt

  942. Association of Acute Venous Thromboembolism With In‐Hospital Outcomes of Coronary Artery Bypass Graft Surgery

    Article • Journal of the American Heart Association, October 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  943. TCT-404 Benefit and Risks of Aspirin on Top of Ticagrelor in Acute Coronary Syndromes: Insights From the Randomized GLOBAL LEADERS Trial

    Article • Journal of the American College of Cardiology, October 2019, Elsevier

    Professor Deepak L Bhatt

  944. Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke

    Article • JAMA Neurology, October 2019, American Medical Association (AMA)

    Professor Deepak L Bhatt

  945. TCT-674 In-Stent Restenosis in Saphenous Vein Grafts: Insights From the DIVA trial

    Article • Journal of the American College of Cardiology, October 2019, Elsevier

    Professor Deepak L Bhatt

  946. TCT-829 Intensity of Lipid Lowering Therapy Among Patients With Prior or New Revascularization: Insights From the GOULD Registry

    Article • Journal of the American College of Cardiology, October 2019, Elsevier

    Professor Deepak L Bhatt

  947. TCT-730 Key Cardiovascular Outcomes After Balloon Expandable Versus Self Expandable Transcatheter Aortic Valve Implantation

    Article • Journal of the American College of Cardiology, October 2019, Elsevier

    Professor Deepak L Bhatt

  948. Preventive Cardiology as a Subspecialty of Cardiovascular Medicine

    Article • Journal of the American College of Cardiology, October 2019, Elsevier

    Professor Deepak L Bhatt

  949. Reply

    Article • Journal of the American College of Cardiology, October 2019, Elsevier

    Professor Deepak L Bhatt

  950. Relationship Between Troponin on Presentation and In‐Hospital Mortality in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

    Article • Journal of the American Heart Association, October 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  951. SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus

    Article • Cell Metabolism, October 2019, Elsevier

    Professor Deepak L Bhatt

  952. Transcatheter versus surgical aortic valve replacement in low-risk surgical patients: A meta-analysis of randomized clinical trials

    Article • Cardiovascular Revascularization Medicine, October 2019, Elsevier

    Professor Deepak L Bhatt

  953. Diabetes Is Associated With Worse Long-term Outcomes in Young Adults After Myocardial Infarction: The Partners YOUNG-MI Registry

    Article • Diabetes Care, September 2019, American Diabetes Association

    Professor Deepak L Bhatt

  954. Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction

    Article • Circulation, September 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  955. Transcatheter Aortic Valve Replacement in Low-Risk Patients

    Article • Circulation, September 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  956. Ticagrelor in Patients with Stable Coronary Disease and Diabetes

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2019, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt, Prof HECTOR BUENO, Professor Dmitry Zateyshchikov

  957. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

    Article • The Lancet, September 2019, Elsevier

    Prof HECTOR BUENO, Professor Dmitry Zateyshchikov, Professor Deepak L Bhatt

  958. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome

    Article • Journal of the American College of Cardiology, September 2019, Elsevier

    Professor Thomas Munzel or Muenzel, Professor Deepak L Bhatt

  959. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

    Article • Journal of the American College of Cardiology, September 2019, Elsevier

    Professor Thomas Munzel or Muenzel, Professor Deepak L Bhatt

  960. Birth and Maturation of Cardio-Oncology

    Article • JACC CardioOncology, September 2019, Elsevier

    Professor Deepak L Bhatt

  961. Drug-Eluting Versus Bare-Metal Stents in Older Patients: A Meta-Analysis of Randomized Controlled Trials

    Article • Cardiovascular Revascularization Medicine, September 2019, Elsevier

    Professor Deepak L Bhatt

  962. Fluorodeoxyglucose Uptake in Atheroma

    Article • Journal of the American College of Cardiology, September 2019, Elsevier

    Professor Deepak L Bhatt

  963. Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin

    Article • Journal of the American College of Cardiology, September 2019, Elsevier

    Professor Deepak L Bhatt

  964. Open Access Publishing and Subsequent Citations Among Articles in Major Cardiovascular Journals

    Article • The American Journal of Medicine, September 2019, Elsevier

    Professor Deepak L Bhatt

  965. Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

    Article • Gastroenterology, September 2019, Elsevier

    Professor Deepak L Bhatt

  966. Temporal Trends and Outcomes of Hospitalizations With Prinzmetal Angina: Perspectives From a National Database

    Article • The American Journal of Medicine, September 2019, Elsevier

    Professor Deepak L Bhatt

  967. Thrombolytic therapy in older acute ischemic stroke patients with gastrointestinal malignancy or recent bleeding

    Article • European Stroke Journal, August 2019, SAGE Publications

    Professor Deepak L Bhatt

  968. Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid–aspirin complex: results of a randomized, crossover, bioequivalence study

    Article • Journal of Thrombosis and Thrombolysis, August 2019, Springer Science + Business Media

    Professor Deepak L Bhatt

  969. Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease

    Article • Circulation, August 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  970. Use of Guideline-Recommended Risk Reduction Strategies Among Patients With Diabetes and Atherosclerotic Cardiovascular Disease

    Article • Circulation, August 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  971. Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2019, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt

  972. Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy

    Article • Journal of the American Heart Association, August 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  973. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    Article • The Lancet Diabetes & Endocrinology, August 2019, Elsevier

    Professor Thomas Munzel or Muenzel, Prof. Francisco Marin , Professor Deepak L Bhatt

  974. Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program

    Article • JAMA Cardiology, August 2019, American Medical Association (AMA)

    Professor Deepak L Bhatt

  975. Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial

    Article • The Lancet Diabetes & Endocrinology, August 2019, Elsevier

    Professor Deepak L Bhatt

  976. Intravenous Tissue Plasminogen Activator in Stroke Mimics

    Article • Circulation Cardiovascular Quality and Outcomes, August 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  977. Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

    Article • Gastroenterology, August 2019, Elsevier

    Professor Deepak L Bhatt

  978. Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles

    Article • Journal of the American College of Cardiology, August 2019, Elsevier

    Professor Deepak L Bhatt

  979. Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI

    Article • JACC Cardiovascular Interventions, August 2019, Elsevier

    Professor Deepak L Bhatt

  980. Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

    Article • JAMA Cardiology, August 2019, American Medical Association (AMA)

    Professor Deepak L Bhatt

  981. Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention

    Article • JACC Cardiovascular Interventions, August 2019, Elsevier

    Professor Deepak L Bhatt

  982. Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 2019, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt

  983. Hospital distance, socioeconomic status, and timely treatment of ischemic stroke

    Article • Neurology, July 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt, Dr. Roland A. Matsouaka

  984. Comparison of Outcomes in Elective Endovascular Aortic Repair vs Open Surgical Repair of Abdominal Aortic Aneurysms

    Article • JAMA Network Open, July 2019, American Medical Association (AMA)

    Professor Deepak L Bhatt

  985. Coronary artery bypass grafting surgery versus percutaneous coronary intervention for coronary artery disease

    Article • Cochrane Database of Systematic Reviews, July 2019, Wiley

    Professor Deepak L Bhatt

  986. Effect of Alirocumab on Mortality After Acute Coronary Syndromes

    Article • Circulation, July 2019, Wolters Kluwer Health

    Professor Thomas Munzel or Muenzel, Professor Deepak L Bhatt

  987. Cohort Study of Repeated Measurements of Serum Urate and Risk of Incident Atrial Fibrillation

    Article • Journal of the American Heart Association, July 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  988. Association of Multiple Enrichment Criteria With Ischemic and Bleeding Risks Among COMPASS-Eligible Patients

    Article • Journal of the American College of Cardiology, July 2019, Elsevier

    Professor Deepak L Bhatt

  989. Cardiovascular Biomarkers After Metabolic Surgery Versus Medical Therapy for Diabetes

    Article • Journal of the American College of Cardiology, July 2019, Elsevier

    Professor Deepak L Bhatt

  990. Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention

    Article • Circulation Cardiovascular Interventions, July 2019, Wolters Kluwer Health

    Professor Deepak L Bhatt

  991. Corrigendum to `Trends in Utilization of Surgical and Transcatheter Mitral Valve Repair in the United States☆’ [The American Journal of Cardiology 123/7 (2019) 1187-1189]

    Article • The American Journal of Cardiology, July 2019, Elsevier

    Professor Deepak L Bhatt

  992. Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI

    Article • Journal of the American College of Cardiology, July 2019, Elsevier

    Professor Deepak L Bhatt

  993. Percutaneous Versus Surgical Pulmonic Valve Implantation for Right Ventricular Outflow Tract Dysfunction

    Article • Cardiovascular Revascularization Medicine, July 2019, Elsevier

    Professor Deepak L Bhatt

  994. Polymeric Heart Valves: Back to the Future?

    Article • Matter, July 2019, Elsevier

    Professor Deepak L Bhatt

  995. Risk of obstructive coronary artery disease and major adverse cardiac events in patients with noncoronary atherosclerosis: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program

    Article • American Heart Journal, July 2019, Elsevier

    Professor Deepak L Bhatt

  996. Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial

    Article • Journal of the American College of Cardiology, July 2019, Elsevier

    Professor Deepak L Bhatt

  997. Vascular Regenerative Cell Exhaustion in Diabetes: Translational Opportunities to Mitigate Cardiometabolic Risk

    Article • Trends in Molecular Medicine, July 2019, Elsevier

    Professor Deepak L Bhatt

  998. The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIX

    Article • Clinical Cardiology, June 2019, Wiley

    Professor Deepak L Bhatt

  999. Efficacy and Safety with Ticagrelor in Patients with Prior Myocardial Infarction in the Approved European label: Insights from PEGASUS-TIMI 54

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, June 2019, Oxford University Press (OUP)

    Professor Deepak L Bhatt

  1000. Bariatric surgery is associated with a lower rate of death after myocardial infarction and stroke: A nationwide study

    Article • Diabetes Obesity and Metabolism, June 2019, Wiley

    Professor Deepak L Bhatt

Showing 1,000 Stories.